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Two approaches have been studied to enhance the 
selectivity of chromatographic systems suitable for 
basic drugs of abuse. The behaviour of nineteen 
compounds has been studied when chromatographed 
using column materials that are low in carbon 
loading. This has permitted the selection of mobile 
phases that are low in organic modifi er, which has 
minimised background UV absorption at 205 nm. Three 
silica-based column materials, namely cyanopropyl-# 
Hypersil SAS and Nucleosil SA gave good 
selectivity. The cyanopropyl- material (Hypersil or 
Spherisorb) is recommended due to its shorter 
analytical times and better stability. In general, 
solutes may be detected down to 2-5 ng on-column. 
The behaviour of seven compounds has been studied 
using a post-column extraction detection system, 
using naphthalene-2-sulphonate as a UV-indicating 
pairing-ion. The design of the system was optimised 
for maximum selectivity, and included testing a 
novel phase separator capable of delivering a very 
high percentage of organic extraction phase to the 
detector. In general, solutes may be detected down 
to 20-100 ng on-column.
Both methods gave linear calibrations and good 
recovery levels for spiked plasma.
vii.
4. The influence of temperature and mobile phase organic 
modifier content upon analyte retention has been 
rationalised by their influence upon analyte pKa 
and log P values. This was achieved by the 
determination of pKa and log P values for nineteen 
compounds in chromatographic mobile phases, and 
other solutions related to them. The results 
indicate that literature pKa values for organic 
amines should be used with caution and should in 
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1.1 DRUGS OF ABUSE
The abuse of drugs generally involves the self 
administration of a drug in a manner and with an effect 
that is not approved of by the medical profession and 
the general public. It is a sociological and medical 
problem that continues to expand every year, and one 
that is increasingly difficult to eradicate. One 
essential aspect of this problem is the development of 
analytical techniques that may be used to identify and 
quantify drugs of abuse, whether as pure drugs, as 
formulated medicines, or as trace amounts present in 
biological fluids such as blood and urine. These 
analytical techniques provide the evidence that is 
required in order to control the illegal possession and 
misuse of drugs. These techniques need to be as simple 
and reliable as possible and applicable to as many 
drugs as possible so as to minimise the number of 
analytical methods required. Gas chromatography (GC) 
employing packed columns has been extensively used for 
a wide range of drugs, including drugs of abuse for 
many years (1). More recently, the superior column 
efficiency of capillary columns have been appreciated, 
especially when linked to a mass spectrometer that is 
able to provide peak identification at high levels of 
sensitivity. However this technique is still very
expensive and cannot yet be regarded as widely 
available as a routine instrument, although mass 
spectrometers specifically designed as GC detectors are 
much less expensive than high resolution instruments.
Over the past ten years, High Performance Liquid 
Chromatography (HPLC) has developed into a highly 
flexible sophisticated and sensitive analytical 
technique that can be regarded as routinely available 
in analytical laboratories. The majority of medicinal 
compounds have a solubility in water that is adequate 
to permit their analysis using aqueous-organic solvent 
mixtures with reversed-phase columns. Additionally, 
most compounds exhibit sufficient absorbance in 
ultraviolet radiation to permit their detection by a UV 
spectrophotometric detector. However, adequate 
detection is very dependent upon the sensitivity 
required to meet the analytical need, so that there are 
many examples of drugs that cannot be adequately 
detected at the levels commonly encountered in plasma 
or urine.
We were aware (2) that a considerable number of 
basic drugs possessed weak UV absorbance, that is 
having molar absorptivities in the region of 200 or 
less. At this level of absorption, compounds are 
required to be present at about 1 mgml-  ^ level in order 
to detect the signal from a 20 |il injection, i.e. 20 yg 
of drug. Anticipated levels in plasma, except in the
case of massive overdose, would normally be in the low 
ngml-1 range, i.e. 10~^ lower than the solution 
required for UV detection. We were advised by the Drugs 
and Toxicology Division of the Home Office Central 
Research Establishment, Aldermaston, that there were a 
number of drugs of this type covered by the Misuse of 
Drugs Act (1971) which could serve as model compounds 
for a study into methods designed to improve 
sensitivity of detection (3). They were all drugs of 
obvious forensic interest and included amphetamine, 
benzphetamine, chlorphentermine, fentanyl, 
mephentermine, methylamphetamine, pethidine, 
phenmetrazine, phendimetrazine, pipradrol and 
methadone. Because many of these compound are tertiary 
amines, chemical derivatization to enhance UV 
absorption or fluorescence is not generally possible.
In these circumstances, an increase in equipment 
complexity is justified, and the main approach was to 
study post-column derivatization using UV-sensitive 
ion-pair reagents. This approach required an extraction 
step using an immiscible organic solvent which meant 
that a phase separator would be needed, to cleanly 
separate the organic phase from the aqueous phase prior 
to passing the organic phase through the detector. 
Preliminary studies had already been made (4) with a 
separattir made to a design by Kinkel and Tomlinson (5) 
that appeared promising for this application. If
successful, a range of chemical derivatization reagents 
could be studied to assess their suitability for 
routine use. The drugs selected for this study were 
chosen on the basis of their importance and 
availability, as indicated in the 28th Edition of 
Martindale (6). The most important group contains drugs 
listed as being currently available, and were 
amphetamine and its metabolite hydroxyamphetamine, 
diphenoxylate, dipipanone, fentanyl, methadone, 
methylamphetamine, normethadone, norpipanone, pethidine 
and piritramide. A second group consisted of drugs now 
discontinued in the UK but perhaps still available 
overseas, and were benzphetamine, chlorphentermine, 
mephentermine, phenmetrazine, phendimetrazine and 
pipradrol. Phenylethylamine was included as a possible 
internal standard for the amphetamine series.
A third group of drugs suggested for study were 
suitable analytically, but were not listed in 
Martindale, and it was considered that future supplies 
would be difficult to obtain. They were allylprodine, 
alphacetylmethadol, alphamethadol, benzethidine, 
diampromide, dioxaphetylbutyrate, noracymethadol, 
phenampromide, properidine and racemoramide. This group 
was excluded from the study.
The nineteen compounds examined in this study are 
stimulant or narcotic primary, secondary or tertiary 
amines, whose UV absorbance at 254 nm is inadequate to
make their detection possible at the ngml  ^ range. An 
appreciation of their physico-chemical properties is 
needed in order to propose satisfactory chromatographic 




Synonym: dextroamphetamine sulphate (+)- 
a-methylphenethylamine sulphate (C^H^N)2H2S04 * m°l* 
wt. = 368.4.
This is a white, odourless crystalline powder with 
melting point above 300° pH 5-6 (1 in 20 solution), 
specific rotation (4% aqueous solution of a dried 
sample) is between 20° and 23.5°. Soluble 1 in 9 water 
and 1 in 800 ethanol, but insoluble in ether. Its 
dissociation constant (pKa) is 9.9 at 20°C. Dexamphet­
amine is unusual in being a (+)-isomer which is more 
active pharmacologically than the corresponding 
(-)-isomer (1, 7-10).
Hydroxyamphetamine sulphate
A white crystalline powder, soluble 1 in 1 of 
water and 1 in 2.5 of ethanol. It is slightly soluble 
in chloroform and almost insoluble in ether. An aqueous 
solution is slightly acidic to litmus (pH about 5), and 
gives a purple colour with ferric chloride solution.
Melting point from 189° to 192°C (6-8, 11).
Phenylethylamine
it is a strongly basic liquid which absorbs carbon 
dioxide from the air. It has a boiling point of 194.5°C 
195°C. It is soluble in water, freely soluble in 
ethanol and ether (7).
Methylamphetamine sulphate
Methylamphetamine is considered to be the N-methyl 
derivative of amphetamines or as a deoxy derivative of 
ephedrine, with a molecular weight of 245.24. The 
sulphate salt is an odourless, white crystalline powder 
with a bitter taste. A 1% solution is neutral or 
slightly acidic to litmus. It is soluble in water, 
alcohol and chloroform, but insoluble in ether and 
acetone. Its melting point range is 171-175°C and a 2% 
solution of it has an optical rotation of +16° to +18° 
(1, 6-11).
Mephentermine sulphate
Mephentermine sulpha-e is N-a,o-trimethyl- 
phenethylamine sulphate dihydrate and contains, on the 
dry basis not less than 98 percent of (C-q H^N) 2H2SO^.
It is an odourless crystal or crystalline powder 
soluble 1 in 20 of water and 1 in 150 of alcohol, 
insoluble in chloroform. A 2% solution in water has a
pH of 4-6.5 while 4.74% solution is iso-osmotic with 
serum (1, 6, 7, 10, 11).
Chlorphentermine hydrochloride
It is a white to off-white crystalline powder, 
odourless and with a bitter taste, melts at about 
235°C. Freely soluble in water and alcohol, sparingly 
soluble in chloroform, practically insoluble in ether. 
The pKa is about 9.6.
Phendimetrazine bitartrate
A white crystalline powder, odourless, bitter 
taste, melts at about 186° with decomposition and has a 
pKa 7.2 It is soluble in water and alcohol.
Pharmetrazine theoclate
It is a white powder soluble in water and ethanol, 
slightly soluble in ether.
Benzphetamine hydrochloride
A white to off-white crystalline powder with 
melting point ranging from 131°-135°. It is soluble in 
waoer, alcohol and chloroform, slightly soluble in 
ether.
1.2.2 Narcotic Analgesics
Analgesics are agents which relieve pain by acting
centrally to elevate the pain threshold without 
disturbing consciousness or altering other sensory 
modalities. The most widely used powerful analgesic, 
morphine, has many undesirable side-effects and this 
has stimulated the development of synthetic 
alternatives (6, 7). However all these compounds retain 
some addictive effects, so that they are subject to 
abuse for their central nervous system effects and have 
become an analytical problem for forensic laboratories.
Fentanyl citrate
This is a white glistening crystalline powder or 
white granules, odourless and tasteless, it is stable 
in air and melts between 147°C and 152°C with a pKa of 
7.3. Soluble 1 in 40 of water, sparingly soluble in 
ethanol, ether and chloroform (1, 6-9, 11).
Pethidine hydrochloride
A white crystalline powder with melting point 
betwen 187°-189°C. Very soluble in water, 1 in 20 of 
ethanol, sparingly soluble in ether, but soluble in 
chloroform. A 2% solution in water has a pH of 4.5-5.5 
and a 4.8% solution is iso-osmotic with serum. It has a 
PKa of 8.7 (1, 6-11).
Pipradrol hydrochloride
It is an odourless, colourless crystal or a white
crystalline powder which melts at about 295° with 
decomposition. Soluble 1 in 30 of water, 1 in 35 of 
ethanol and 1 in 1000 of chloroform, almost insoluble 
in ether. It has a pKa of 9.71. A 1% solution in 
water has a pH of 5 to 7 (1, 6).
Piritramide
A crystalline powder with melting point of 149° to 
150°c.Soluble in dilute acetic acid, slightly soluble 
in water (1,6).
Methadone hydrochloride
Odourless, colourless crystals or crystalline 
powder with bitter taste. Melts between 233°-236°C. 
Soluble 1 in 12 of water, 1 in 7 of ethanol and 1 in 3 
of chloroform, insoluble in ether. A 1% solution in 
wacer has a pH of 4.5 to 6.5 (1, 6-11).
Normethadone hydrochloride
Crystals with melting point 174°-177°, soluble in 
wacer and alcohol. A 1% solution in water has a pH of 
about 5(1, 6).
Dipipanone hydrochloride
An almost colourless, white crystalline powder 
wich a bitter numbing and burning taste. Melting point 
124°-127°. Soluble 1 in 40 of water, 1 in 1.5 alcohol
and 1 in 6 of acetone, insoluble in ether. A 2.5% 
solution in water has a pH of 4-6 (1, 6-11).
Norpipanone hydrochloride
Crystals with melting point from 181° to 182°C. 
Soluble in water and alcohol (1, 6).
1.3 PHARMACOLOGICAL ACTIONS AND USES
Sympathomimetic amines are classified as a group 
of basic compounds which mimic the effects of 
stimulation of the sympathetic nerves to the organs of 
the body (11). The amphetamines may be considered 
together because of similar pharmacological properties 
which they possess, “hey are sympathomimetic compounds 
and the dominant fearure of these drugs is their porent 
stimulatory action on the central nervous system (OS), 
in addition to the peripheral a  and 6 actions commcn to 
the sympathomimetic drugs (11, 12).
Some of the characteristics of this stimulating 
action on the CNS are facilitation of thoughts, 
improvement of physical performance, analepsis, 
elevation of fatigue levels, increased confidence, 
elation and euphoria. All these desirable effects are 
often followed by a "rebound" to a state of depression 
and fatigue. Peripherally, it produces vasocon­
striction, contraction of the bladder, sphincter and 
relaxes the bronchial muscle. The amphetamines are
therapeutically said to have the following indications 
(11):
a) Hyperkinetic behavioural disorders in children 
with brain damage are calmed by controlled doses of 
amphetamines although they are used as long term 
treatment, paradoxically, tolerance is rare.
b) Dextroamphetamine has been used to control 
exogenous obesity more effectively than a racemic 
mixture, but it is usually not recommended for periods 
longer than 6-10 weeks to avoid tolerance.
c) Narcolepsy, in this case it controls the symptoms, 
but it is not curative. The dextro-isomer is more 
effective than the laevo-isomer, but there is the 
tendency of developing tolerance to the drug.
Usually, the term narcotic refers to a drug that 
diminishes sensibility, relieves pain and induces 
lethargy, drowsiness, or sleep. Narcotics .produce 
indifference both to physical discomfort and to mental 
anguish. Chronic suppression of central nervous system 
function results in a dependent state in which the drug 
must be taken regularly.
Dexamphetamine
This is an indirectly acting sympathomimetic 
compound with weak peripheral but strong CNS stimulant 
actions. As a central stimulant, the dextro-rotatory 
isomer is about twice as potent as the racemic mixture
(amphetamine) and 3-4 times as potent as the 
laeveo-rotatory isomer. The actions and uses are as 
mentioned for sympathomimetics. As an anorectic agent, 
it has been supplanted by anorexiants with weaker 
euphoric actions, to which tolerance develops less 
rapidly. It has been used as a pressor agent in 
orthostatic hypotension and in spinal anesthesia.
Hydroxyamphetamine
Hydroxyamphetamine is an indirect sympathomimetic, 
the actions of which are both a and B agonise in 
nature, it is essentially devoid of central nervous 
activity. It is used topically as a nasal decongestant 
and together with atropine as a mydriatic agent. The 
para substituted hydroxy group markedly alters the 
pharmacodynamic properties of amphetamine. It is 2-4 
times more active as a pressor agent therefore 
increasing blood pressure especially in spinal 
anesthesia and orthostatic hypotension by myocardial 
stimulation and peripheral vasoconstriction.
Methylamphetamine
This is a central stimulant with an analeptic 
effect greater than that of amphetamine. It had been 
used to antagonise barbiturate hypnosis, for the relief 
of mental and physical fatigue and counteract acute 
alcoholism, it acts directly on the a and B receptors and
is .used in the management of hypotension associated 
with spinal anesthesia.
Mephentermine
It is a compound with strong a-adrenergic activity 
and is therefore used in the management of various 
states of hypotension and in the treatment of nasal 
congestion.
Chiorphentamine
It is generally recommended for use as an adjunct 
co lessen appetite in the management of obesity. There 
is not sufficient evidence to show that it has any 
primary effect on appetite-control centres of the 
hypothalamus. The anorexigenic effect is temporary. 
Chlorphentamine produces less stimulation of the 
central nervous system than other anorexiants of the 
amphetamine type.
Phendimetrazine
It is an indirectly acting sympathomimetic. It is 
used as an appetite suppressant.
Phenmetrazine
It is used as an anorexigenic agent, for which it 
is.about equal to dextroamphetamine. Studies have 
indicated that phenmetrazine may have greater relative
central stimulatory activity than amphetamine.
Benzphetamine
It is only approved for use as an anorexiant (i.e. 
in the treatment of obesity), in which role it is about 
as efficient as dextroamphetamine.
Pipradrol
Pipradrol has been reported to be of use in the 
treatment of fatigue.
Fentanyl
Fentanyl is a potent narcotic analgesic with rapid 
onset and short duration of action. Its pharmacological 
actions are similar to morphine. Equal analgesia can be 
obtained with a dose 1/150 that of morphine.
It is used primarily as an analgesic.for the 
control of pain associated with all types of surgery.
It can also be used as a supplement to all agents 
commonly employed for general and regional anesthesia. 
It is also an ingredient in fentanyl citrate and 
droperidol injection.
Pethidine
Pethidine is less powerful than morphine but has 
considerbly shorter duration of action. Depending on 
the route of administration, the analgesic action of
15.
pethidine is observed within 15 minutes reaching a peak 
in about an hour and subsiding in 2 to 4 hours. Since 
it reduces the sensitivity of labour pains without 
seriously diminishing the force of uterine contraction, 
pethidine is used as an obstetric analgesic, it may 
however prolong labour. It has also been substituted 
for morphine in both pre- operative and post-operative 
medication. It is sometimes used in association with 
local and spinal anaesthetics and to supplement nitrous 
oxide and oxygen anaesthesia.
Piritramide
It has analgesic uses similar to those of morphine 
and is discussed under narcotic analgesics.
Methadone
It is used as an analgesic to relieve moderate to 
severe pain, particularly in chronic conditions, pain 
in post-operative states is lessened by the drug. It is 
also used as an antitussive, suppressing the cough 
reflex, but such use may lead to addiction. The 
principal actions of therapeutic value are those of 
analgesia, sedation and detoxification or temporary 
maintenance in narcotic addiction.
Normethadone
It is used mainly as a cough suppressant, but its
action and general use are as discussed under narcotic 
analgesics.
Dipipanone
This is a potent analgesic related to methadone.
It has relatively little sedative and hypnotic action 
compared with methadone. It can be used to maintain 
relief of pain when morphine or pethidine has ceased to 
be effective.
Norpipanone




(i) Capsules, tablets and sustained release forms 
containing from 2.5 to 20 mg of dexamphetamine sulphate 
alone or in combination with any of the following: 
methylamphetamine, amylobarbitone, phenobarbitone, 
aspirin, phenacetin, codeine trifluroperazine, 
meprobamate, methaqualone and vitamins.
(ii) Elixirs, containing 1 mg/ml of dexamphetamine 
sulphate alone or with amylobarbitone.
Recommended doses
a) Narcolepsy: Adults 1060 mg daily in divided doses.
b) Minimal brain dysfunction: children over 3 years 
old: 5-40 mg daily in divided doses.
c) Barbiturate poisoning: 10-50 mg/ml in a slow 
intravenous drip.
d) Exogenous obesity: Adults 5-10 mg taken 30 to 60 
minutes before meals.
Hydroxyamphetamine
(i) Ophthalmic solution (1%) isotonic with tears.
(ii) Tablets: 20 mg
Recommended doses
a) Postural hypotension: 60-400 mg orally in divided 
doses.
b) Heart block: 20-60 mg three or four times a day.
c) Mydriatic: 1-2 drops of 1% ophthalmic solution.
d) Carotid sinus syndrome: 20-60 mg orally.
Methylamphetamine hydrochloride B.P.
Capsules or tablets containing from 2.5 to 10 mg 
alone or in combination with amphetamine or 
dexamphetamine sulphate, phenobarbitone or phenytoin.
Recommended doses
a) Analeptic: Adults: 15-60 mg orally or 30 mg I.V. 
or I. M . '•
b) Antidepressant: Adults 5-60 mg daily in divided
doses.
c) Anorexic: 2.5-5 mg before meals.
d) Pressor agent: 10-30 mg I.M. and 5-10 mg I.V. 
drip.
Mephentermine sulphate
(i) Mephentermine sulphate is available in several 
injection forms containing 15-30 mg/ml, tablets 
containing 12.5-25 mg.
(ii) Nasal drops: 0.5% solution.
Recommended doses
a) Treatment of shock: 20 mg I.M. or 30-60 I.V.
b) Treatment of hypotension associated with spinal 
anesthesia:
Adult: 30-45 mg I.M. or 12.5-25 mg adminsitered 
orally 1 or 2 times daily.
Children: 0.4 mg per kg administered orally, I.M. 
or slowly I.V.
Chlorphentermine hydrochloride 
Tablets, 65 mg as chlorphentermine base.
Recommended doses
a) Anorexic: orally, user over 12 years of age only: 
65 mg of the base once a day.
Phendimetrazine bitartrate
Tablets containing 35 mg.
Recommended doses
Anorexic: Adult: 17.5 - 70 mg 2 or 3 times daily orally 
one hour before meals.
Phenmetrazine hydrochloride
Tablets containing 25 mg and timed-release tablets 
containing 50 mg and 75 mg.
Recommended doses
Anorexic: Adults only: 25 mg 1 to 3 times a day, 
adminstered orally one hour before meals or 50 mg or 
75 mg a day as a single prolonged-action tablet taken 1 
hour before breakfast.
Benzphetamine hydrochloride 
Tablets containing 25 mg and 50 mg.
Recommended doses
Anorexic: Adults only: from 25 to 50 mg 1 to 3 
times daily. It is recommended to start with 25 mg and 
increase gradually as necessary.
Pipradrol hydrochloride (6, 7)
Tablets containing 1 and 2.5 mg.
Recommenced doses
The usual starting dose for adults with depressive 
states is 2.5 mg 3 times daily, given orally. Elderly 
patients may receive 1 mg, once or twice daily.
Fentanyl citrate
Injection containing 0.05 mg of fentanyl base per 
ml, in 2 ml ampules.
Recommenced doses
The manufacturer's recommended dose of fentanyl 
citrate for pre-operative medication is 0.05 to 0.1 mg 
(expressed as fentanyl base), administrated 
intramuscularly. The same dose is to be used 
post-operatively every 2 to 3 hours as required. By 
intravenous injection the equivalent of 100 to 600 
micrograr.s of fentanyl (9).
Pethidine hydrochloride (4, 6, 7)
1) Meperidine hydrochloride injection (U.S.P.). A 
sterile solution of pethidine hydrochloride in water 
for injections pH 3.5 to 6.
2) Meperidine hydrochloride syrup (U.S.P.). A syrup 
containing pethidine hydrochloride pH 3.5 to 3.9. Store 
in airtight containers. Protect from light.
3) Meperidine hydrochloride tablets (U.S.P.). Tablets 
containing pethidine hydrochloride. Protect from light.
4) Pethidine injection (B.P.). Pethidine 
hydrochloride injection. A sterile solution of 
pethidine hydrochloride in water for injections. 
Sterilised by autoclaving.
5) Pethidine tablets (B.P.). Pethidine hydrochloride 
tablets. Tablets of 25 mg and 50 mg.
Recommended doses
a) Injection by subcutaneous or intramuscular, 25 to 
100 mg; by intravenous, 25 to 50 mg.
b) Tablets.* 50 to 100 mg.
Piritramide (7)
Available as 2 ml ampoules of an injection 
containing 10 mg per ml.
Recommended doses
20 mg intramuscularly appeared to be equal in 
analgesic effect to morphine. 15 mg intramuscularly.
Methadone hydrochloride (7)
1) Methadone hydrochloride injection (U.S.P.). A 
sterile solution of methadone hydrochloride 9.5 to 
10.5 mg per ml in water for injections pH 3 to 6.5. 
Protect from light.
2) Methadone injection (B.P.). Amidone hydrochloride 
injection. A sterile solution of methadone hydro-
chloride injection. A sterile solution of methadone 
hydrochloride in water for injections. It is 
distributed in ampoules and sterilised by autoclaving 5 
mg/ml and 10 mg/ml.
3) Methadone hydrochloride oral solution (U.S.P.). 
This is methadone hydrochloride 9 to 11 mg in each meal 
with a suitable preservative, it may contain suitable 
colouring and flavouring agents and surfactants pH 3 to 
6. To be diluted with water before being taken. Store 
at 15° to 30° in airtight containers. Protect from 
light. Tablets of 5mg methadone hydrochloride.
Recommended doses
a) Injection by subcutaneous means, 5 to 10 mg.
b) Tablets: 5 to 10 mg
Normethadone hydrochloride 
(same as Methadone hydrochloride)
Dipipanone hydrochloride (6)
a) Dipipanone injection B.P. A sterile solution of 
dipipanone hydrochloride in water for injection. The 
acidity is adjusted to pH 4.5 by the addition of 
hydrochloric acid. Sterilized by autoclaving. Protect 
from light.
b) Diconal tablets: Scored tablets each containing
lOmg dipipanone hydrochloride and 30mg of cyclizine
hydrochloride.
Recommended doses
1) Tablers. Oral: One Diconal Tablet repeated every
6 hours, if necessary. If this dosage is not enough, 
it may be increased by increments of half a tablet.
2) Subcutaneous or Intramuscular injections of 12.5 
mg to 25 mg of bipipanone hydrochloride repeated every 
6 hours if necessary.
Norpipanone hydrochloride
Same as Dipipanone
1.5 METABOLISM, EXCRETION AND TOXICITY
It is now possible to suggest potential 
metabolites of a drug from its chemical Structure. The 
metabolism of compounds related to amphetamine has been 
extensively examined because of experimental and 
clinical interests in the compounds (13, 14) and the 
possible involvement of metabolites in their 
pharmacology. The metabolic pathways for these 
compounds are of more general interest because 
amphetamine has structural elements common to many 
other classes of drugs. Metabolism of narcotic 
analgesics have also been investigated, but it is more 
difficult z o  have a general metabolic pathway for them 
as in amphetamine because most of them are not
structurally related and as such are treated on an
*
individual basis.
Examining the structure of amphetamines suggests 
six main routes of metabolism (15, 16) while, 
amphetamine - a metabolite of methylamphetamine, 
suggests four routes, these are summarised in Fig. 1.1.
1. Aliphatic hydroxylation of the three carbon atoms 
of the side chain is pharmacologically important, 
although quantitatively minor, since its products are 
ephedrines. Unlike most other drug metabolism 
reactions, it is not carried out in the liver but in 
the noradrenergic nerves of the central and peripheral 
nervous systems, by the enzyme dopamine-B-hydroxylase. 
It is a stereoselective reaction restricted to the 
dextro-isomers which may account for the more 
pronounced pharmacological properties of the dextro 
compared with the laevo isomer.
2. Aromatic hydroxylation of the 2,3 or 4 positions 
of the benzene ring with the possibility of 
dihydroxylation . In fact it has only been observed in 
the para position and occurs extensively and 
consistently in the rat.
3. N-dealkylation of compounds bearing a substituent 
on the amino nitrogen. This is of the greatest 
quantitative significance and involves an oxidative 
process requiring molecular oxygen and NADPH. 'It _ 
occurs in the microsomal fractions of the liver cells
and gives rise to formaldehyde in equal molecular 
amounts to the primary amine formed.
4. Oxidative deamination to a ketone, which may then 
be reduced to an alcohol, and further oxidation leads
to production of a benzoic acid.
5. N-Oxidation yields hydroxylamines, oximes and
-nitroalkanes.
Both oxidative deamination and N-oxidation occurs in 
microsomal fraction of the liver cells.
6. Conjugation of the amino nitrogen - the
hydroxylated metabolites are generally excreted partly 
free and partly conjugated with either glucuronic or 
sulphuric acid depending on the species. In man, 
p-hydroxyamphetamine is excreted as its sulphate 
conjugate.
Methylamphetamine
It is readily absorbed after oral administration. 
About 70% of a dose is excreted in the urine in 24 
hours. Under normal conditions up to 43% of a dose is 
excreted as unchanged drug, up to 15% as
4-hydroxymethylamphetamine, and about 5% as amphetamine 
which is the major active metabolite.
Excretion of unchanged drug is dependent on the urinary 
pH - the percentage is increased in acidic urine and 
greatly reduced (to about 2% of a dose) if the urine is 
alkaline.
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In plasma, usually in the range of 0.01 to 0.05 
ng/ml.
Toxicity: The estimated minimum lethal dose is 1 gm 
p-Hydroxyamphetamine
It is readily absorbed after oral administration. 
About 90% of a dose is excreted in the urine in 24 
hours as free and conjugated hydroxyamphetamine, with 
about 4% of the dose as free and conjugated 4-hydroxy- 
norephedrine.
Toxicity: The estimated minimum lethal dose,
intranasally in children up to 2 years of age is 200 mg 
and in adults about 2 gm.
Phendimetrazine
It is readily absorbed after oral administration 
metabolised by N-demethylation to phenmetrazine, which 
is active, and by N-oxidation. About 5 to 30% of a 
dose is excreted in the urine unchanged in 24 hours 
together with up to 30% as phenmetrazine and 20% as the 
N-oxide. Plasma level is about 0.07 ug/ml in about one 
hour.
Half-Life: Plasma half-life is about 2 to 3 hours.
Phenmetrazine 














Phenmetrazine is readily absorbed after oral 
administration. About 70% of a dose is excreted in the 
urine in 24 hours with about 19% as unchanged drug, 19% 
as the lactam (5-methyl-3-oxo-6-phenyl morphoiine), 12% 
as free 4-Hydroxyphenmetrazine, 10% as conjugated 
4-hydroxyphenmetrazine and about 5% as the N-oxide. 
Phenmetrazine is a metabolite of phendimetrazine.
Plasma level concentration 0.16 Mg/ml in about 2 hours. 
Toxicity: Estimated minimum lethal dose for children up 
to 2 years,of age is 200 mg.
Half-life: Plasma half-life is about 8 hours.
Chlorphentermine
It is absorbed after oral administration and 
metabolised mainly by N-oxidation and N-hydroxylation 
to nitro and hydyroxylamine derivatives. Excretion in 
urine is dependent upon urinary pH, a much greater 
proportion of unchanged drug is excreted when the urine 
is acidic than when it is alkaline. In normal urine, 
about 17% of a dose is excreted unchanged and about 50% 
as N-oxidised metabolites in 48 hours. If urine is 
maintained at an acidic pH, these proportions are 
approximately reversed, and about 70% of a dose will be 
excreted in 24 hours. In alkaline urine, less than 12% 
of a dose is excreted unchanged in 48 hours. Plasma 
level is about 0.32 ug/ml in 4 hours.
Half-Life: Plasma half-life is about 40 hours.
Phenethylamine
Phenethylamine is the putrefactive base obtained 
from phenylalanine by decarboxylation.
Mephentermine
Mephentermine is readily absorbed after oral or 
parenteral administration and rapidly metabolised by 
demethylation and hydroxylation. About 50 to 85% of a 
dose is excreted in the urine unchanged together with 
15 to 20% as phentermine. Conjugated v 
N-hydroxymephentermine has also been detected in the
urine in small quantities.
Toxicity: The estimated minimum lethal dose in
children up to 2 years of age is 200 mg and in adults 
is 2 gm.
Half-Life: From urinary excretion data, the half-life
of mephentermine is about 6 to 20 hours.
Benzphetamine
Benzphetamine is readily absorbed after oral 
administration and mainly excreted in the urine as 
amphetamine and methylamphetamine, very little is 
excreted as unchanged drug.
Fentanyl
This is rapidly metabolised in the liver. Two 
metabolites, norfentanyl and despropionylfentanyl, have 
been detected in plasma at concentrations similar to 
those of fentanyl. About 70% of a dose is excreted in 
the urine in 72 hours mostly as metabolites,, with about 
10 to 20% of a dose being excreted as unchanged drug in 
48 hours. About 9% of a dose is eliminated in the 
faeces.
Toxicity: The estimated minimum lethal dose is 2 mg.
Half-Life: Plasma half-life is about 1 to 6 hours
(dose dependent).
Pethidine
Pethidine is readily absorbed after oral 
administration and rapidly and extensively distributed 
throughout the tissues. The major metabolites are 
N-demethylatea derivative norpethidine and the 
hydrolysis product, pethidinic acid and its conjugates. 
Excretion of pethidine and its metabolites is dependent 
on the urinary pH. In normal subjects about 70% of a 
dose is excreued in the urine in about 24 hours, up to 
10% as unchanged drug, 20% as pethidinic acid, 16% as 
conjugated peihidinic acid and 8% as norpethidinic acid 
and 10% as conjugated norpethidinic acid.
Urinary excretion of pethidine and norpethidine 
may both be enhanced to about 30% of a dose if the 
urine is acid, in alkaline urine, less than 5% is 
excreted as pethidine and norpethidine. Usually, the 
plasma level concentration is about 0.2 to 0.8 yg/ml. 
Toxicity: The estimated minimum lethal dose is 1 gm.
Half-Life: Plasma half-life is about 3 to 10 hours
(mean 5) but it is increased in neonates and in renal 
impairment.
Methadone
Methadone is rapidly absorbed after oral 
administration and widely distributed in the tissues. 
The main metabolic reaction is N-deme^thylation 
resulting in a substance which spontaneously cyclises
to form the major metabolites, 2-ethylidene-l,5- 
dimethyl-3,3-diphenyl-pyrrolidine (EDDP) and 
2-ethyl-5-methyl-3,3- diphenyl-l-pyrroline (EMDP), 
neither of which are active. In subjects on methadone 
maintenance, about 20 to 60% of a dose is excreted in 
the urine in 24 hours with up to about 33% of the dose 
as unchanged drug and up to about 43% as EDDP. EMDP is 
about 5 to 10% of the dose. Urinary excretion of 
unchanged drug is pH-dependent, it is increased in acid 
urine.
Plasma level concentration is about 0.05 to 1.0 yg/ml. 
Toxicity: The estimated minimum lethal dose is 50mg.
Dipipanone
Dipipanone is absorbed after oral administration 
with rapid onset of action. It is excreted in the 
urine and faeces. Blood level concentration is about 
1.6 yg/ml.
Toxicity: The estimated minimum lethal dose is 0.1 gm.
1.6. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
1.6.1. History
Many forms of chromatographic methods are in use 
extensively as separative and analytical techniques.
Gas chromatography seems to have dominated the scene 
since its introduction by Martin and James (17). Liquid 
chromatography has been developed into thin-layer,
ion-exchange, exclusion (gel filtration and gel 
permeation) and paper chromatography mode.Even though 
Giddings (18) in the mid 1960's had already shown 
advantages of liquid chromatography over gas 
chromatography, liquid chromatography on a comparable 
basis to gas chromatography is usually attributed to 
■the work of Huber and Hulsman (19).
The success of gas-liquid chromatography and the 
need to develop silica packing materials caused some 
delay for the development of HPLC but since the 
developments of pellicular packings (20-22), porous 
silica and alumina microparticles of 5 ym, 10 urn and 
recently 3 ym (23, 24) and chemically bonded phases 
(25), the development of HPLC has progressed so rapidly 
that it is now the most extensively used 
chromatographic technique for separation, detection and 
quantification.
All these qualities are some of the main reasons why 
this technique has been used for the work carried out 
in this thesis.
1.6.2. Definitions
The following are some of the expressions that 
have been used in this thesis:
a. Band Broadening (Column Efficiency)
As a solute band progresses through a column, the
band width (w) increases and the solute is diluted by
calculate the theoretical plate number (N) of the 
column.
base and width at half the height of the peak 
respectively. The value of N is expected to be almost 
constant for different bands in a chromatogram, for a 
given set of operating conditions and is therefore a 
measure of the column efficiency (26).
This parameter was calculated for all the columns 
packed and used in this study.
In comparing column efficiencies a more useful 
parameter is the height equivalent to a theoretical 
plate, HETP or plate value H (which is a quantitative 
value for band spreading). The value N is proportional 
to column length L where:
This value depends on the material and column 
design as well as the operating conditions. A very 
useful guide to column efficiency is the reduced plate 
height h given by
the mobile phase. This band width is normally used to
2 2
N = 16 (^) (1.1)
where tr, W and are the retention time,width of the
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h = h  ( 1 - 3)
where dp is the diameter of the stationary phase 
particles.
b . Retention
Capacity ratio, k' is the term used to describe 
solute retention in column liquid chromatography. 
Retention and subsequently the separation of components 
in a mixture depends on the relative distribution of 
each component between the two chromatographic phases.
c . v  v
k' = = kd V- 0.4)
m m  m
where C and V are the solute concentrations in and 
volumes of mobile phase (m) and the stationary phase 
(s) respectively. KD is the distribution ratio of the 
solute between the two phases.
The capacity ratio may also be written as
t t
  (1-5)o
where t and tQ are the elution times of the retained 
and unretalned peaks respectively.
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C. Resolution and Selectivity
The resolution, Rs of two adjacent solute bands is 
defined as being equal to the distance between the two 
band centres, divided by the average band width
t2 ”  tl
Rs " Js(W2+W1) (1.6)
where t^ and t2 are the elution times of solutes 1 and 
2 and W^, W2 are the respective widths at the base of 
their peaks. The above may also be expressed as
Rs = i /N w r >  (1.7)
where k'2 is the capacity ratio of the second peak, and 
a is the selectivity factor which is given by
k '
2
« = FT- (1.8)
K 1
d . Functional Group Contribution Value
Due to the importance of selectivity, Huber (76) 
suggested that there is a need to develop a reliable 
selectivity index, based on structural differences. 
This is then represented by
k'2
T = log a = log -j-f—  (1.9)
K 1
where k'^ and are capacity ratios of solutes 1 and 
2 respectively which differ only by a functional group, 
where solute 1 is taken as the parent compound.
A functional group may contribute positively or 
negatively to retention, therefore x may be positive or 
negative.
1.6.3 Stationary phases
Generally, liquid chromatography phase systems 
are classified as straight phase (or normal phase) and 
reversed phase depending on the nature of the 
stationary and mobile phases.
In straight phase systems, the stationary phase is 
more polar than the mobile phase, which is principally 
a mixture of organic solvents. In reversed phase 
systems, the stationary phase is non-polar whilst the 
mobile phase is polar.
In HPLC the stationary phase may be a porous solid 
like silica (24), carbon (28), polymeric resin (29,30) 
or most commonly a liquid chemically bonded to a porous 
silica material <31.32).
1.6.4 Retention Mechanisms
The different mechanisms by which separations may 
be achieved in liquid chromatography gives it major 
advantages over other separation techniques.
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a ) Liquid-Liquid (Partition) Chromatography
Liquid-Liquid or partition chromatography was
developed by Martin and Synge. This method involves 
the use of a liquid stationary phase, which is obtained 
by filling the internal pores of a finely divided inert 
support. The sample to be analysed is dissolved in the 
mobile phase and its components are partitioned between 
the stationary phase and mobile phase according to 
their partition coefficients. Because of the variety 
of stationary phases available, this method is a 
versatile mode of liquid chromatography and a wide 
variety of compounds, both polar and non-polar can be 
separated.
b ) Liquid-Solid (Adsorption) Chromatography
The original form of liquid chromatography was 
liquid-solid chromatography as developed by Tswett, 
using 'classical' column chromatography. Separation is 
by a liquid mobile phase and a solid stationary phase 
which reversibly adsorbs the solute molecules. The 
stationary phase may be either polar (e.g. silica gel, 
alumina) while the mobile phase would be relatively 
non-polar e.g. hexane or chloroform or it could be 
non-polar (e.g. Polymer beads) while a polar mobile 
would be used (e.g. water or.ethanol). This latter 
method is known as reverse phase adsorption (75).'- The 
retention of samples in liquid-solid chromatography is
more predictable than in liquid-liquid chromatography 
since the elution order follows the polarity of the 
solutes. This is most successfully applied to 
non-ionic samples of intermediate molecular weight 
(200-2000) which are soluble in organic solvents.
Ionic compounds usually give rise to 'tailing' peaks, 
because of the high surface energies of the adsorbents, 
unless the surface is deactivated in some way.
c . Bonded Phase Chromatography
This category has the most widely used materials 
in HPLC. These materials have hydrocarbon chains which 
are usually linear and bonded to the silica surface.
The octadecysilane (ODS) derivative is the most cited 
material in HPLC literature and it has remarkable 
solute selectivity. Percentage of carbon loadings vary 
from 5 to 22%, the extent of silanol capping, the 
surface area, pore diameter and particle shape of the 
silica to which it is bonded all also vary. The mobile 
phases used are aqueous containing an organic modifier 
such as methanol or acetonitrile in order to reduce 
solute retention, and buffered at a pH that enhances 
selectivity between similar compounds. The retention 
mechanism is complex and as such not fully understood.
Horvath and Melander (33) proposed that solutes 
having some hydrophobicity are squeezed out of the 
aqueous mobile phase and into the hydrocarbon brush
because solute interactions with water are weaker than 
interactions between water molecules - this was called 
the Hydrophobic Effect.
This effect is increased with an increase in 
carbon loading and the carbon chain length. It has 
been observed that both increase in hydrophobic area of 
the solute and increase in mobile phase surface 
tension, cause increase in solute retention.
The control of pH is essential for ionisable 
solutes because solute-solvent interaction due to polar 
functions reduce retention. It has been shown by Scott 
and Kucera (34) that when an organic modifier is used 
to wet the surface of the bonded phase, then a 
monolayer of organic modifier is adsorbed at the 
hydrocarbon surface. Furthermore, they demonstrated 
that this layer is not displaced by solute and so must 
take part in the retention mechanism.
d ) Ion-Exchange Chromatography
Ion Exchange chromatography which has been in use 
as a separative technique for some years now is a form 
of adsorption chromatography. The mode involves the 
substitution of one ionic species for another. The 
stationary phase consists of a rigid matrix, the 
surface of which carries a net positive charge to give 
an ion-exchange site (A+ ) If a mobile phase containing 
anions is used, the exchange site will attract and hold
a negative^counter-ion (B ). Sample anions (D ) may 
then exchange with the counter-ions (B ). The process 
can be represented in terms of an equilibrium:
This process is known as anion exchange. Bonded 
quaternary ammonium compounds give strong cationic 
groups suitable for exchanging acidic solutes, and 
similarly bonded alkyl sulphonic acid may be used to 
exchange cations.
Separation of samples is based on the strength of 
the interactions between the sample ions and the 
exchange site. Ions that interact weakly with the 
exchange site will be poorly retained and will have 
small k' values, while ions that have strong 
interactions will be strongly retained and will have 
high k' values.
e . Ion-Pair Chromatography
Ion-pair chromatography is a special form of 
liquid-liquid chromatography used for the separation of 
ionic or ionizable compounds (35, 36). In its most 
usual form, it is used in reversed phase mode with a 
hydrocarbon bonded stationary phase. Ion-pair 
extraction is a technique with which ionized compounds 
can be made to favour the organic phase during an 
extraction by using' suitable counter-ions to form ion 
pairs according to the equation:
(1.10)
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where Y is the pairing-ion and the mobile and 
stationary phases are represented by subscripts aq and 
org respectively.




tX+W ° a q
(1.12)
The pairing-ion, Y is usually present in
relatively high concentrations in the aqueous phase and
is associated with its counter-ion. The solute X+ isaq
present in small concentrations. This demonstrates that 







Methanol, acetonitrile, tetrahydrofuran, hexane, 
chloroform, propan-2-ol were of HPLC grade and were 
used without further purification. Sentan-l-ol was of 
Laboratory Reagent grade, and all the above solvents 
were supplied by Fisons Ltd., Loughborough, U.K..
Octan -l-ol was of Laboratory Reagent grade and 
supplied by Aldrich Chemical Co. Ltd., Gillingham, 
Dorset, U.K. The water used for the preparation of 
aqueous mobile phases was double distilled from an all 
glass still and deionised by passage through an 
Elgastat* deioniser, (Elga Products, Buckingham, U.K.). 
Deionised water was also obtained from Milli-Ro and 
Milli-Q water purification systems.
















Hydrochloric acid May & Baker, Dagenham
























Pethidine hydrochloride May & Baker Ltd., 
C.R.E.
Piritramide Janssen Pharmaceutical 
Ltd., C.R.E.
Fentanyl citrate Janssen Pharmaceutical 
Ltd., C.R.E.
Normethadone hydrochloride C.R.E.
Methadone hydrochloride Wellcome, C.R.E.
Norpipanone hydrochloride Wellcome, C.R.E.
Dipipanone hydrochloride Wellcome, C.R.E.
C.R.E. - Central Research Establishment
Forensic Science Service, Home Office, 
Aldermaston
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1
c h3
Sodium dodecyl sulphate (SDDS)
Naphthalene-2-Sulphonate Sodium Salt (NS)
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B. Solutes (1)
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C H 3» C H / C O * C * ( C H 2) . n (c H 3) Normethadone
C cH6* *5
C6H 5 CH:
CH3*C H 2- C O - C 'C H 2* C H 'N (C H 3) 2 Methadone
c 6h 5
6^^*5
CH 2-CH 2-C -CO -CH 2-CH 3
CcH6n 5
c 6h 5
c h 3- c h -c h 2- c - c o -c h 2- c h 3
Norpipanone
N« c 6h 5 Dipipanone
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2.1.4 HPLC packing materials 
Cable 2.3. Packing materials used
PACKING MATERIAL MANUFACTURER
Spherisorb 5 CN Phase Sep.






.able 2. 4. Summary of columns employed in this study. 
Column diameters were 4.6 mm except for 








3 Partisil-SCX 150 10
c Partisil-SCX 100 5
D SAS-Hypersil 100 5
- SAS-Hypersil 100 5
r Nucleosil SA 100 5
vj Nucleosil SA 50 5
- PRP-1 150 10
- ODS-Hypersil 150 5
- Hypersi1-Phenyl 100 5
Table 2.5. Summary of some of the properties of the packing materials used.
Column
Code












A Cyanopropyl- 3.5 200 8 Spherical Not known





D Trimethyl- 2.6 200 12 Spherical Not
E Trimethyl- 2.6 200 12 Spherical required
F + G benzenesulphonic
acid 10 Spherical Nil
H divinylbenzene 415 7.5 Spherical Not require
I Octadecylsilane- 10.0 12 Spherical Full
J Phenylpropyl- 5.0 220 8 Spherical Not known
2.2 EQUIPMENT
2.2.1 HPLC Instrumentation
The HPLC instrumentation used was assembled from 
commercially available components. Fig. 2.3 shows a 
generalized scheme of the liquid chromatograph used.
The pump used was either a Constametric III or a , 
Milton Roy Minipump with pulse dampener (both from LDC, 
Stone). Sample injections were made by means of 50ul 
and 100)il syringes (Hamilton type 75N, Phase 
Separations, QueensferryJthrough a valve injector 
(Rheodyne 7125, Jones Chromatography, Llanbradach) 
having a 20,ul loop volume.
The column eluent was monitored by UV-Spectro- 
metry, using the following detectors:- Cecil CE212, 
Cecil 2102 variable wavelength spectrophotometer (Cecil 
Instruments, Cambridge, England) U .V-Spectrophotometer 
(Du Pont Instruments, Herts, England). A Perkin-Elmer 
550-S UV-Vis spectrophotometer (Perkin-Elmer Ltd., 
Slough, England) was used for non-HPLC spectroscopic 
measurements.
The chromatography columns consisted of both 2mm 
and 4.6mm internal diameter (%" external diameter) 
stainless steel tubes of various lengths (supplied by 
HETP, Macclesfield, U.K.). The column end fitting 
consisted of a low dead-volume swagelok connection with 
a 1/16" outlet which was connected to the detector by 

















Fig. 2.3. Generalised Scheme of the Liquid Chromatograph.
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Low dead-volume 1/16" stainless steel tubing (internal 
diameter 0.15 mm) was used to connect the injection 
valve to the top of the column. Other connections were 
made using stainless steel tubing and standard swagelok 
fittings (HETP). All connections were made as short as 
possible.
The temperatures of the columns, injector and 
mobile phase reservoir were controlled by immersion in 
a heated water bath (Gallenkamp type 400-010)wherever 
practical.
2.2.2. HPLC Column packing apparatus
The column packing apparatus (see Fig. 2.4) 
consisted of a stainless steel 'bomb' 75 ml in volume 
which served as the slurry reservoir. One end cf the 
'bomb' was connected to a pneumatic amplifier pump (SAT 
RIG column packer, Haskel Energy Systems Ltd.) and the 
other end was attached to a % ” external diameter 
stainless steel guard column. Iso-propanol and hexane 
were used for column packing. Procedure is described 
in section 2.3.1.
2.2.3. Segmented flow system
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Fig. 2.4. Column Packing Apparatus
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2.5. HPLC with Post-Column Reactor
(a ) Pumping devices
The organic phase was pumped into the system via a 
coiled k ” stainless steel tube which was pressurised 
from a cylinder of nitrogen gas via control valves, and 
the flow rate of the organic solvent was then adjusted 
by changing the pressure of the nitrogen gas. This 
eguipment was a gift from ICI Pharmaceuticals Ltd., 
Macclesfield, Cheshire.
A multi-channel peristaltic pump (Gilson 
Minipulse-2; Anachen, Luton, U.K.) was used to create 
suction for the aqueous organic and waste lines of the 
phase separator when necessary.
(b) Phase separator
Two types of phase separators of slightly
different designs were used in this work. Phase
separator I was made to a design described, by Kinkel
and Tomlinson (37), which was a modification of a
>
design by Copsey (38). It consists of one surface of 
PTFE and another of glass both surfaces being 
channelled to make a separating chamber of aproximately 
28 yl in volume. A cross- section is shown in Fig.
2.7. The two surfaces are enclosed in a cylindrical 
brass jacket made to hold the glass and PTFE blocks 
together tightly to prevent leakage at normal flow 
rates. The orientation of the separator is chosen so 
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Figure 2.7. Cross-Section of Phase Separator I.
surface of the lower block (glass or PTFE).
Phase separator II was designed by T.M. Jefferies, 
(Bath University). It is similar to phase separator I 
but is larger and has extra channels for cleaning-up 
any droplets of aqueous phase from the organic phase 
and vice-versa. A cross-section is shown in Fig. 2.8.
2.2.4 Flow-Injection Analysis
The post-column reactor (Fig. 2.5) including the 
phase separator, may be used independently without an 
HPLC column as a flow-injection analysis system.
Aqueous reagent is pumped directly through the 
injection valve to a mixing column.
To start up the system, organic phase only was 
supplied to ensure the absence of leaks and the absence 
of water droplets in the detector. Aqueous phase was 
then supplied, either by using the HPLC system or an 
independent pump or.the peristaltic pump as required.
The system can be used for the determination of 
physico- chemical properties such as partition 
coefficient and pKa values. The transfer of a solute 
into an organic phase can be measured as previously 
described following an injection of the solute into the 
aqueous system (Pulse Input), or by pumping an aqueous 
solution of the solute into the organic phase (Step 
Input). 'It permits a sufficient volume of organic 
phase-containing solute - to be collected and studied 
separately by spectrophotometer.
Figure 2.8.
Configuration of phase separator for monitoring 
the organic phase.
Flowpath of organic phase:
1. Aqueous/organic segmented flow inlet
2. Separated organic phase plus some aqueous droplets
3. Re-entry into second separating channel
4. Exit of clean, organic phase to detector
Flowpath of aqueous phase:
1. Aqueous/organic segmented flow inlet
5. Exit of aqueous phase
6 Exit of any water droplets + some organic phase
The separator may also be configured to monitor the 
aqueous phase by connecting exit 5 to re-entry 7 and 
connection of exit 8 to the detector.





Figure 2 . 8 . Three-dimensional diagram of Phase Separator 
II. Legend on opposite page.
2.3. GENERAL PROCEDURES
2.3.1. Column packing and preparation
Most of the columns used were packed, using the 
equipment described in Fig. 2.4, employing iso-propanol 
to make the slurry and hexane as the packing solvent 
(recommended by Shandon, Cheshire, U.K.). Column 
lengths were either purchased already treated with 
nitric acid, or if not, were soaked in 2N nitric acid 
for 1-2 hours and rinsed, and dried. After that, the 
bottom end of the column was fitted with mesh and 
ferrule while the top is fitted with only the ferrule. 
The 'bomb' (slurry reservoir) is then cleaned with 
methanol and dried with compressed (pressurised) air.
To pack a column (100 mm x 4.6 mm i.d), 1.4 g of the 
packing material was weighed into a 50 ml beaker and 
dispersed in 25 ml of iso-propanol by immersion in an 
ultrasonic bath. The reservoir was filled with hexane.
The head pressure of the nitrogen cylinder was turned 
up to 120 lb/in2 and the pump was set to recycle, to 
completely fill the system with the packing solvent. 
With the bottom end of the column closed, it was filled 
with iso-propanol and then attached to the slurry 
reservoir.
The slurry was then added to the slurry reservoir 
to completely fill the reservoir. The slurry reservoir 
and column were then attached to the pump. The pump 
was then charged to a pressure of 7000 p.s.i., the
column end opened and the valve was then released.
About 300 ml of hexane was pumped through the column at 
the set pressure and then reduced gradually to zero.
The valve was then shut-off and the column allowed to 
stand for about 10 minutes. It was then removed and 
topped with excess material from the 'bomb' before a 
2 urn stainless steel mesh frit was placed on top of the - 
packing before swageing on the column end. The column 
was then washed with methanol, and stored until 
required.
The mobile phase is usually recycled through the 
column for some hours before use and where an ion-pair 
reagent is present, then the pump is run overnight to 
stabilise the column.
2.3.2 Preparation of mobile phases
Aqueous mobile phases were prepared by pipetting 
the appropriate amounts of organic modifier, buffer and 
pairing-ion (when used) solutions into grade B 
volumetric flasks and adjusting to volume with double 
distilled, deionised water. The final volume 
adjustment was made after cooling the mobile phase to 
room temperature. The pH of the mobile phase was 
adjusted by dropwise addition of (85%) H^PO^ or ammonia 
solution (98%) and the pH was measured using a PTI-6 
Universal Digital pH Meter. The. pH of solutions 
prepared in this way are denoted in this thesis by pH*.
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In other cases the pH of purely aqueous buffers were 
adjusted and then organic solvent added. Before the 
mobile phase was used, it was filtered through a 
filtering apparatus with a 0.45um pore membrane filter, 
and purged with helium for 10 minutes to remove 
dissolved gases in solution.
2.3.3 Preparation of Organic phase
The solvent used for the segmented flow
experiments was a mixture of chloroform and pentan-l-ol 
(90 + 10 v/v). This mixture was equilibrated with the 
aqueous phase (aqueous reagent and mobile phase). 
Usually the organic phase was shaken for 15 minutes 
with aqueous phase in a separating flask, the organic 
layer removed, filtered and degassed before use.
2.4 EXTRACTION OF DRUGS FROM BIOLOGICAL FLUIDS
a ) Protein precipitation
To plasma (0.5 ml) 5% trichloroacetic acid (2 ml) 
was added and shaken thoroughly. The precipitated 
plasma proteins were separated from the solution by 
centrifugation at 3000rpm for 15 minutes. The clear 
supernatant was removed for extraction using XAD-2 
resin.
b ) Extraction
Samples of supernatant, up to 10 ml, were made
alkaline with 5N-sodium hydroxide to pH 12.0 (pka+2) 
e.g. Chlorphentermine, Normethadone, Dexamphetamine.
The solutions were then introduced onto 'columns' (5 ml 
graduated pipettes) each containing about 1.5 g of 
clean XAD-2 resin (Amberlite, B.D.H. Poole, U.K.). The 
resin had previously been washed with methanol, acetone 
and water. These columns produced flow rates of about
2.5 ml/min. The columns containing the adsorbed 
solutes were washed with 10ml of water and then eluted 
with 20 mis of chloroform: isopropanol (3:1). Ethanolic 
hydrochloric acid 6N (lOO^il) was added to the organic 
eluate which was then evaporated to dryness under 
vacuum using a rotary evaporator (Buchi Rotavapor-R). 
The residue was then dissolved in a known quantity of 
the H.P.L.C. mobile phase for direct injection or post 
column derivatisation.
2.5 ANALYTICAL PROCEDURES
Known quantities of compounds of interest were 
spiked into plasma and were assayed after the 
appropriate pretreatment by comparison with analytical 
standards of known concentration. The assays were 
performed using one of the compounds as internal 
standard in as much as the compounds did not interfere 
with each other (i.e. well separated). A single 
standard solution of the compounds''was injected ten 
times to determine precision of the injection
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procedure. Standard deviation of the peak heights, or 
peak height ratios were determined.
Peak height ratios of 5 to 8 standard solutions 
containing a range of solute concentrations were used to 
prepare calibration graphs. The maximum concentration 
ranges used were up to twice the expected concen­
tration. Each solution was injected in triplicate and 
the data fitted to:-
y = mx + c (2.1)
where y is the peak height ratio, x is the 
concentration of solute and m and c are regression 
coefficients for slope and intercept respectively. The 
concentrations of the unknown samples analysed were 
determined by comparison of their response wich the 
responses obtained from two or three analytical 
standards of known concentration whose linearity of 
response had previously been confirmed.
2.5.1 Post column derivatisation for Ultra violet 
detection
Ion-pair reagent solution of appropriate 
concentration was filtered and well degassed with 
helium before teing pumped to the T-connection at the 
end of the H.P.L.C. column.
Both pH and flow rate of the reagent were adjusted 
such that the desired pH for ion-pairing with the 
compounds eluted from the H.P.L.C. column was achieved.
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The derivatisation reagent and H.P.L.C. eluent were 
then passed into a mixing column (50 mm x 4.6 mm I.D) 
to assist rapid and uniform ion-pair formation to 
occur. The mixing column was cooled with ice when 
necessary to stabilise baseline noise in the detector, 
caused by chromatography carried out at temperatures 
above room temperature. This then passes on to mix 
with the immiscible organic solvent via a 'T'-piece 
(Fig. 2.6) which forms the segments which subsequently 
passes through the extraction coil (Fig. 2.5) and then 
the phase separator after which the phase of interest 
is monitored through the UV-detector.
2.6 DETERMINATION OF IONISATION CONSTANTS
The method used was that described by Albert and 
Serjeant (58). a solution was made of the amine 
compound to be measured at a concentration of 0.5 mmol 
in 50 ml, (i.e. 0.01 M solution). This volume was 
placed in a 100 ml beaker and titrated with 0.1 M 
sodium hydroxide, which was added in 0.5 ml portions 
and the pH values were recorded. A total of 5 ml base 
was added and calculations were made to correct for the 
chances in stoichiometric concentrations so as to give 
a maximum of nine values for the pKa. The pKa values 
of each compound were determined in different solvent 
compositions and temperatures'' and are listed in Table
4.2.
The pH. values were measured using a thermometer 
electrode and a combined glass/calomel electrode 
connected to an EIL Model 23A direct Reading pH meter. 
Each determination was made in duplicate.
In order to gain an appreciation of the 
comparability of the results obtained using the above 
equipment and technique the pKa values of several 
substances were determined with published values as 
standards.
2.7 DETERMINATION OP PARTITION COEFFICIENTS
Several methods by different authors have been 
described for partition coefficient determinations, and 
the most extensively used method is by simply shaking a 
solute with two immiscible solvents and then analyzing 
the concentration in one or both phases. Partition 
coefficients in octanol-water systems are frequently 
used for characterization of hydrophobic properties of 
drugs. It is claimed that the 1-octanol-water system 
is a satisfactory model for the biological system, 
because the organic phase is not completely non-polar 
and contains a significant amount of water in a stable, 
hydrogen-bonded complex.
The method used here is that described by Leo 
et al (40). The two immiscible phases used for the 
experiments are:- Octan-l-ol and the appropriate buffer 
solution at chromatographic pH without the organic
modifier. The two phases were equilibrated with each
-4 -2other and filtered prior to dissolution of 10 - 10 M
solute in the aqueous buffer phase. The organic phase
and the aqueous phase containing the solute were shaken
by simple inversion 100 times in five minutes in a 50ml
centrifuge tube fitted with a glass stopper.
A calibration was prepared for each compound over
-4 -2the concentration range 10 - 10 M in aqueous phase.
The absorbance of a known concentration of solute in 
aqueous phase was then determined before partition with 
octan-l-ol and then after partition and centrifugation; 
the quantity left in che aqueous phase was determined by 
relating the absorbance to its concentrations on the 
calibration plot. The partition coefficients is then 
calculated as follows:-
where Co is the concentration of the solute in the 
organic phase, and Cw is the concentration of the 
solute in the aqueous phase.
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SECTION 3. RESULTS AND DISCUSSION
THE EXAMINATION OF VARIOUS STATIONARY PHASES 
FOR THE ANALYSIS OF SOME DRUGS OF ABUSE
3.1 Cyanopropyl-bonded silica
3.1.1 The Stationary Phase
The basis of all the bonded silica materials is
the unbonded silica, which for Spherisorb materials is
a totally porous, spherical material having a surface 
2 -1area of 220 m g and a mean pore diameter of 8 nm 
(range 5.4 to 11 nm). It is available in three particle 
size ranges (3, 5 and 10 ym).
Cyanopropyl-bonded silicas are generally 
marketed as normal phase materials intended for the 
chromatography of polyfunctional aromatic compounds, 
using organic solvent mixtures such as hexane and 
propan-2-ol. Under these conditions, it is a weaker 
hydrogen-bonding adsorbent than underivatized silica 
and so produces narrower peaks for these compounds. For 
example:
Solute-Solvent Solute-Cyano-silica
R - OH ;:NC.CH3 R-OHv.:ilC-CH2CH2CH2“Si-
I
However, they have properties that make them suitable 
for rapid chromatography using reversed-phase 
conditions.
The percentage carbon loading is low, for 
example, for the Spherisorb range of -CN, -0DS1 and 
0DS2 derivatized silicas, the values are 3.5, 7.0 and 
12.0% w/w respectively, whilst the -CN surface coverage 
is better (0.6 nuM/g) compared to the ODS materials (0.3 
and 0.5 mM/g respectively)which helps to minimise the 
effect of any uncerivatised silanol groups.
Additionally the -CN group introduces polar properties 
(41) (log P = -1.07) onto the propyl chain (3 x -CH2~, 
log P = 1.59) that should reduce solute retention when 
compared to a propyl chain plus a terminal -CH^ group 
(log P = 0.70). It also permits solutes to interact by 
hydrogen-bonding and thus adds ’different' selectivity.
To further reduce solute retention a short 
column (50 mm x 4.6 mm i.d.) was packed and used at 30^ 
rather than at room temperature. This should then 
provide chromatographic conditions that may also be 
employed for post-column reactions designed to improve 
solute detectability. Preliminary investigation showed 
that the phase separator unit would be unable to 
clearly separate chloroform from an aqueous phase 
containing more than 25 percent v/v methanol or 25% v/v 
methanol-acetonitrile mixture. Another restriction in 
the choice of chromatographic conditions was the need 
to employ low concentrations of buffers since cations 
such as Na+ and K+ tended to facilitate the transfer of 
pairing-ions from an aqueous to an organic phase. Since
it was intended to employ the highly UV-absorbing 
compound naphthalene-2-sulphonic acid to transfer 
amines into the chloroform phase, the unwanted transfer 
of ion-pair reagent by buffer salts would generate a 
high UV-absorbing background signal. This would make 
the post-column system difficult to stabilise or 
operate at high sensitivity levels.
3.1.2 Investigation of chromatographic conditions
using cyanopropyl-bonded silica
Chromatographic conditions were investigated to 
produce good resolution within as short a 
chromatographic run-time as possible. As a starting 
point, it was decided to employ a short column of 50 mm 
length with equal volumes of methanol and acetonitrile 
diluted with 0.05 M phosphate buffer.
3.1.2a Influence of Mobile Phase pH
In view of the importance of mobile phase pH, 
its influence on the retention of Group A solutes was 
studied using 0.05 M phosphate buffer-methanol- 
acetonitrile (90:5:5, v/v/v). Retentions of all 
solvents (Fig. 3.1) fell with pH as expected, but did 
not re^ch their minimum values over the pH range 
(5.4-7.2) of this buffer. It has been reported (42) 
that the pKa values of 30 basic drugs when measured in 
methanol-aqueous buffer (pH 4 or 7) were lower than
Figure 3.1 Influence of mobile phase pH on the 
retention of some Group A compounds. 
Conditions: 5 ym Spherisorb-CN column 
(50 x 4.6 mm i.d.) with 0.05 M phosphate 
buffer-methanol-acetonitrile (90:5:5, 
v/v/v) at 30°C. Injection volume 10 yl, 
flow rate 1 ml.min monitored at 205 nm 
with 0.04 a .u .f .s .








7 Methylamphetamine 1 0 . 1 0
8 Mephentermine 10.40
9 Phendimetrazine 7.60



















Figure 3.1. Solute codes as on opposite 
page.
Figure 3.2 Influence of mobile phase pH on the 
retention of some Group B compounds. 
Mobile phase, 0.005 M phosphate 
buffer-propan-2-ol-acetonitrile (65: 17.5 
17.5, v/v/v). Other conditions as in Fig.
3.1. Solute codes as on opposite page.
Codes and Literature pKa for Group B Compounds
No Compound pKa
1 1 Pethidine 8.70






















Solute codes as on opposite page.
literature aqueous pKa values. However, considering 
that four of the compounds in Fig. 3.1 have pKa's 
between 9.6 and 10.4 (1), it was not expected that a
total of 1 0 % organic modifier would have such a marked
effect on pKa. The relationship between solute 
retention, solute pKa and mobile phase pH was examined 
further, and is discussed in Section 4. For practical 
purposes, this study showed that the k' range could be
varied between 0.5 and 2.0 at pH 5.4 and from 2 to 12
at pH 7.2.
A similar study was carried out for Group B 
solutes. Fig. 3.2 shows the same influence of mobile 
phase pH on solute retention as demonstrated in Fig.
3.1. The pH range was extended to 4.0 using 0.005 M 
KH2 PO 4 solution adjusted to pH by the addition of 
orthophosporic acid, and most solutes were eluted 
closer to their minimum k' values, i.e. the values 
expected when mobile phase pH is less than solute pKa 
-2. At this pH, protonation of the amines should be 
100%. Since resolution was good at pH 4.0, this value 
was selected for further studies.
3.1.2b Influence of organic modifiers
At a buffer pH of 7.2 and a constant 5% v/v 
acetonitrile, the percentage of methanol in the mobile 
phase wasr increased stepwise up to 15% v/v for some 
Group A compounds. Figure 3.3 shows that solute log k'
values decreased linearly up to a point, however it 
will be noticed that the effect is greater on some 
drugs than others, but these differences are small and 
not an important consideration. From Table 3.1 which 
shows the effect of an increase in methanol 
concentration on methylamphetamine and two of its 
metabolites (p-hydroxyamphetamine and dexamphetamine), 
it could be observed that, gradually separation between 
them decreases, also phenmetrazine and phendimetrazine 
from Figure 3.3. It is of interest to note that the 
effect is quite significant on methylamphetamine, 
mephentermine and phendimetrazine - this could be due 
to the effect of a methyl group which is attached to 
the nitrogen atom, and this is common to all the three 
compounds. 1 0  percent v/v methanol was chosen for 
further investigation because it gave narrower peak 
shapes, reasonable k' values with fair resolution.
The effect of organic modifiers was also studied 
on Group B compounds and Figures 3.4 to 3.7 show that 
larger volumes of organic modifiers were required to 
achieve small k* values for these compounds because 
they are more hydrophobic than Group A compounds.
Recently it has been proposed that the solvent 
strength of a mobile phase may be measured by 
calculation of its partition coefficient, P (43). ThisO
has been suggested because in reversed-phase HPLC, the 
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Log Percentage Methanol
gure 3.3 Influence of mobile phase methanol content on the retention
some Group A compounds. All other conditions as in Fig. 3.10
Table 3.1. The relationship between the methanol 
concentration in the mobile phase and 
the capacity ratio (k’) and selectivity (a) 
of p-hydroxyamphetamine (POHA), 
dexamphetamine (DEX ) and methylamphetamine 
(METH). Chromatographic conditions as in 
Figure 3.1.
Methanol POHA DEX METH
% v/v k' a k ' a k'
5.00 2.33 1.75 4.08 2 . 1 0 8.58
1 0 . 0 0 1.38 1.67 2.30 1 . 6 6 3.81
12.50 1 . 1 0 1.60 1.75 1.57 2.74
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Figure 3.4 Influence of mobile phase propan-2-ol content on the retention of some






















Figure 3.5 Influence of mobile phase acetonitrile content on the




















_    12
*        11
0 'I ------------------------------------------------ 1------------------------------------------------1------------------------— -— — — i
25 35
Percentage (v/v) tetrahydrofuran
Figure 3.6 Influence of mobile phase tetrahydrofuran (THF) content on the
retention of some Group B compounds.
CO
Conditions for Figure 3.7
In all investigations 65% v/v 0.2 M phosphate 
buffer (pH 3.1)was used with:
A. 35% v/v Tetrahydrofuran (THF)
B. 35% v/v Propan-2- ol (Pr-2-OH)
C. 35% v/v Acetonitrile (ACN)
D. 17. 5% : 17.5% v/v Pr- 2-OH-ACN
E. 17. 5%: 17.5% v/v THF-ACN
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Mobile Phase Composition
Figure 3.7 Effect of the combination of different organic solvent mixtures
00
in the mobile phase on the retention of some Group B c o m p o u n d s .Solute J°
codes as in Fig. 3.2. Mobile phase composition code as on opposite page.
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the hydrocarbonaceous surface of the stationary phase 
and the solvent 'strength' of the mobile phase. When 
water is the mobile phase, then solute retention is 
dominated by the 'hydrophobic' effect and for aqueous- 
organic solvent mixtures it is the 'solvophobic' effect 
(44-48).
Solute retentions are also correlated to their 
n-octanol-water partition coefficients (logp ) (42), 
even though it is difficult to describe reversed-phase 
HPLC as a partition process. The partition coefficients 
of water, methanol, acetonitrile, propan-2 -ol and 
tetrahydrofuran expressed as log P values are -1.38, 
-0.82, -0.34, +0.30 and +0.46 respectively (43).
The partition coefficient of a solvent mixture 
may be calculated as the sum of the mole fraction of 
each solvent present X, its log P value,O
n
namely log P„ = z Xs.log P .J 3 si i=1 i s i
where m = mixture
= mole fraction of ith solvent 
log Pg  ^ = n-octanol-water log P for ith solvent 
n = total number of solvents in the 
mixture.
The organic modifiers used in the optimization study 
have been examined using this approach to determine 
whether solute retentions may be reliably explained on 
this basis. The log Pg values for the single solvent-

















The experimental k' values obtained with 35% of
tetrahydrofuran and acetonitrile are very similar,
having k' differences <±5%, whilst although
propan-2 -ol shows some selectivity differences, these
are .small and change k* by ±10%. The calculated
partition coefficient values for these three solvent
compositions are also very similar. However, when two
organic modifiers are present with water then this
approach does not explain the experimental k' values
because they are lower than predicted. This is most
pronounced whenever propan-2 -ol is present, for example
with propan-2-ol-acetonitrile- water (17.5; 17.5; 65%
v/v/v), the value for log P = -1.218, which is
s m
identical to that for acetonitrile- water (35; 65% v/v)
and yet k' values are reduced by 25% (pethidine 5.8 to
4.2, dipipanone 16.2 to 10.2).
For propan-2-ol-tetrahydrofuran-water (17.5;
17.5; 65% v/v/v) the value for log P„ = -1.203,
sm
which is similar to that for tetrahydrofuran-water (35; 
65% v/v) at -1.187, but the k 1 values are reduced by 10
to 20% (pethidine 5.2 to 4.7, dipipanone 16.0 to 12.2).
It is likely that the different selective 
solute-solvent interactions of the solvents are partly 
responsible, because when two solvents are present 
together, then their solvating ability must be to some 
extent, additive. Another reason for the difficulty in 
applying the concept of partition coefficient as a 
solvent strength parameter in this particular case is 
that the concept was proposed following a study of the 
retention behaviour of unionized solutes. In this case 
the solutes are protonated amines at pH 4.0, in the 
presence of potassium dihydrogen phosphate and 
phosphoric acid.
It is likely that the amines are present in 
solution as ion-pairs with phosphate ions, so that 
their positive charge is partially neutralised. 
Furthermore this is a very different solute type from 
solutes such as benzonitrile, benzophenone and other 
similar compounds used in the log P study. The3
measurement of solvent strength using the Snyder 
Polarity index P' was also developed using unionised 
solutes and so is also unable to be used for the 
conditions described here. The concept of solvent 
selectivity as proposed by Rohrschneider (49) and 
Snyder (50) and then developed by Glajach et al.. (51) 
into an optimization strategy is very helpful, and 
applicable to ionizable and unionizable solutes.
The relevant properties of the solvents used in
this study are:
X x X P'e d n
Pr-2-ol 0.55 0.29 0.27 3.9
THF 0.38 0 . 2 0 0.42 4.0
ACN 0.31 0.27 0.42 5.8
where Xe = proton acceptor contribution
Xd = proton donor contribution
Xn = strong dipole interaction
P ' = solvent polarity
They show that THF and ACN have a similar 
emphasis on solute-solvent interactions, namely
>  >  X, whereas the interactions of Pr-2-ol aren e d
X0  > xn > x(3 * This suggests that the optimum mixture 
for maximising the various solute-solvent interactions 
would be Pr-2-ol with either THF or ACN, and the 
experimental k' values in Fig. 3.7 show that retentions 
are reduced more when propan-2-ol is present. For a 
mobile phase at pH 4.0 with 0.005 M KH2 PC>4, 35% v/v of 
any one of these solvents produced very similar 
retentions in the k* range 4-16, with very little 
selectivity changes. When mixed in equal volumes 
propan-2-ol-acetonitrile reduced the k' range to 4-10, 
whilst propan-2-ol-THF gave 4-15. This suggests that no 
specific solute-solvent interactions sufficiently
important to influence retention order. It further 
suggests that hydrophobicity (log P) of solute is the 
most important property that influences the order of 
elution of these compounds under the above conditions.
A chromatogram of Group B compounds under conditions 
selected for minimum, reproducible k' values is given 
in Fig. 3.10b, and shows good selectivity and 
sensitivity ( 1 2  ng each solute on-column).
3.1.2c Influence of Buffer Concentration
The influence of buffer molarity on solute
retention was studied over the range 0.005 M to 0.05 M.
Retention was reduced for all solutes with increase in
buffer concentration, Figure 3.8. The range
0.025-0.05 M was preferred because it would routinely
produce more reproducible k' values due to the
relatively small decrease in these values in this
range. It is probable that phosphate ions form
ion-pairs with protonated solutes, especially since at 
2-
pH 7.2 HPO^ ions rather than H2 P04 1 0 ns,
predominate. The uncertainty surrounding pKa values in 
the presence of organic modifier makes the estimation 
of this effect difficult, although the results are of 
practical value. A chromatogram of the ten compounds in 
Group A optimised for pH, buffer and organic solvents 
show good resolution and sensitivity (6 - 1 2  ng each 
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3 . 8  Influence of mobile phase buffer ionic
strength on some Group A compounds. Mobile 
phase pH was 5.4.
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Figure 3.9 Influence of mobile phase buffer ionic strength 
retention of some Group B compounds.
on
Conditions for Figure 3.10(a)
5 - urn CPS - Hypersil column (50 x 4.6 rnn.i.d) with 0.025 M 
Phosphate buffer (pH 7.2) - methanol-acetonitrile (90:5:5, 
V/V/V) at 30°C, 1 ml.min.  ^flowrate monitored at 205 nm, 
0.04 a.u.f.s.
Injection volume (10 u 1) contained 6-12 ng of each solute.
Conditions for Figure 3.10(b)
Same as fig 3.10(a) but with a mobile phase of 0.02 M 
Phosphate buffer (pH 4.0) - propan-2-ol-acetonitrile 
(65:17.5:17.5, V/V/V).
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Figures.10 Chromatograms of Group A (a) and Group B
(b) compounds. Conditions as on opposite 
pace. Solute codes as in Figures 3.1 and 
3.2 respectively.
minutes, Figure 3.10a.
The influence of buffer molarity on solute 
retention for Group B compounds, showed the same 
relationship as for Group A. It is interesting that for 
six solutes in Group A, retentions at 0.005 M were in
the range log k' 1.0 - 1.4 and fell to log k' 0.4 - 0.8
at 0.05 M whilst seven solutes in Group B having a log 
k' range of 1.05 - 1.48 at 0.005 M similarly fell to 
log k' 0.4 - 0.8 at 0.05 M buffer, Figure 3.9. 
Considering the mobile phase pH was 7.2 for Group A and 
4.0 for Group B, this suggests that ion-pair formation 
between protonated solute and phosphate anions cannot 
be the main factor in the effect that buffer has upon 
solute retention. The solute pKa range in Group A (6 . 8  
- 10.4) is very similar to the seven solutes considered
in Group B (6 . 6  - 9.2).
3.1.3 Quantitative Aspect
The suitability of the procedures obtained for 
cyanopropyl-bonded silica for quantitative 
determinations was examined using a 50 x 4.6 mm i.d. 
column (conditions as described in Figure 3.10). 
Six-point calibrations were made for dexamphetamine, 
phenmetrazine, methylamphetamine and mephentermine in 
mobile phase, over the concentration 0.25 - 5 (ig ml~^. 
The results are shown in Table 3.2 and Figures 
3.11a-3.11d. Linear relationships were obtained between
Table 3.2. Statistical analysis of results for the calibration of dexamphetamine (DEX), 
phenmetrazine (PHEN), methylamphetamine (METH) and mephentermine (MEPH) and 
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Figure 3.11a Calibration of dexamphetamine (0.25-5.0 M g . m l ” '1').
Control (----- ) and extract from spiked plasma ( . . ...... )











1 0 0 "
30 2 V 51
Concentration (yg.ml
Figure 3.11b Calibration of phenmetrazine (0.25-5.0 pg.ml 1 ). Control (----- )
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Figure 3.11c Calibration of methylamphetamine (0.25-3.75 yg.ml ^) , Control (---- )
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Figure 3.lid Calibration of mephentermine (0.25-5.0 yg.ml ^), Control (---- )
and extract from spiked plasma (****). Conditions as in Fig. 3.10a.
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peak height and concentration of solute for duplicate 
injections, with intercepts not significantly different 
from zero. Correlation coefficients for each 
calibration were >0.999 and relative standard 
deviations (RSD) for the slopes were ± 0.32, 0.94, 1-. 9 
and 0.41% respectively. Identical calibrations were 
tnade by spiking plasma with the same stock calibration 
solutions, followed by their extraction as described in 
Section 2.4. Linear relationships were obtained as 
before, with intercepts not significant; correlation 
coefficients were 0.996, 0.999, 0.977 and 0.999 
respectively. The percentage recovery of solutes from 
plasma, calculated as the spike calibration 
slope/control calibration slope, xlOO was found to be 
80.8, 86.3, 81.1 and 98.7% respectively. All these 
calibrations had been made without the benefit of an 
internal standard in order to test the quantitative 
behaviour of each solute. The calibrations show this to 
be satisfactory, permitting any one solute to be used 
as an internal standard for the other solutes.
This quantitative aspect was extended to a Group 
B compound and its metabolite (methadone and 
normethadone) with dipipanone as the Internal Standard 
using the chromatographic conditions described in 
Figure 3.10b and the statistical results are shown in 
Table 3.3 and Figures 3.12a-3.13b. Concentration range 
was 0.25-5.0 ug.ml The calibrations were carried out
-1
Table 3.3. Statistical analysis of normethadone and methadone (0.25-5.0 yg.ml ) using dipipanone as internal 
standard. Chromatographic conditions as in Figure 3.10b.
• NORMETHADONE 
PEAK HEIGHT PEAK HEIGHT
RATIO
Control Plasma Control Plasma
METHADONE
PEAK HEIGHT PEAK HEIGHT ,
RATIO ,




Std. dev. of 
slope
Intercept
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Figure 3.12a Calibration of methadone, using peak heights (mm) 0.25-5.0 ug.ml-1).
Control (---- ) and extract from spiked plasma (***'). Conditions





gure 3.12b Calibration of methadone, using peak height ratios.
All other conditions as in Figure 3.10b.
c=
Concentration (yg.ml )
Figure 3.13a Calibration of normethadone using peak heights (mm) (0.25-5.0 yg.ml ^ ), 
control (----- ) and extract from spiked plasma (****). Conditions
i



















32 V 58 i
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Figure 3.13b Calibration of normethadone, using peak height ratios.
All other conditions as in Figure 3.10(b).
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using both peak heights and peak height ratios, for 
comparison and to check the suitability of the system. 
Linear relationships were also obtained in all cases. 
With peak heights against concentration correlation 
coefficients for both methadone and normethadone were
0.999 and relative standard deviations for the slopes 
were ±0.92% and ±2.05% respectively. For identical 
calibration of extracted spiked plasma with the same 
stock calibration solutions, correlation coefficients 
were>0.999 and relative standard deviations were± 2 .1 % 
and ±2.2% respectively. In all cases the intercepts 
were not significant. When peak heights were used for 
calibrations, correlation coefficients were>0.999 for 
both control and plasma extract and relative standard 
deviations were±1.90% and ±1.36% respectively.
In order to make the method more readily 
applicable to other workers, a commercially available 
100 x 2.1 mm i.d. cartridge column containing 5 urn 
cyanopropyl-silica was tested for Group B compounds.
The column temperature was raised to 40°C in order to 
reduce the organic modifier content from 35% to 24%, 
thus reducing the background noise (absorbance) at 
205 nm. Figure 3.14 shows that good resolution was 
obtained with similar capacity factors (1.5-9.0) and 
column efficiency (N = 900-1350) to those in Figure 
3.10b, although there wag slight tendency for some peak 
asymmetry (AS = 1.0-1.3), Table 3.4. Six point
Figure 3.14 Chromatogram of the separation of
Group B compounds. Conditions: 5 yin
Spheri-Cyano cartridge column (100 x 2.1 mm
i.d.) with a mobile phase of 0.025 M phosphate
buffer - propan-2 -ol - acetonitrile
(76: 12: 12- v/v/v) at 40°C. Injection
volume (10 yl). Flow rate was
0.5 ml.min monitored at 205 nm with








Table 3.4. Summary of the capacity ratio (k*),
resolution (R_), column efficiency (N) and &
peak asymmetry (As) of some Group B 
compounds. Conditions as in Figure 3.14.
Compound k' N As Rs
Pethidine 1.4 798 1 . 0
3.6
Benzphetamine 3.4 1086 1.3
2.3
Normethadone 5.2 1165 1.35
1 . 6
Methadone 6 . 8 1357 1.17
1 . 6
Norpipanone 8.75 1219 1.3
1.9
Dipipanone 1 2 . 1 952 2.3
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calibrations were made for a mixture of pethidine, 
benzphetamine, normethadone, methadone and dipipanone, 
over the concentration range 0.7-18 pg ml  ^ using 
norpipanone as internal standard (Figure 3.15). Linear 
relationships between peak area ratios and solute 
concentration were obtained (Figure 3.16) with 
correlation coefficients >0.998 and intercepts not 
significant. The precision (n = 7) for each solute 
solution gave relative standard deviations of ±1.45, 
1.27, 0.87, 0.55 and 4.7% respectively at the 9 pg ml  ^
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(a) (b)
Figure 3.15. Chromatograms of highest (a) and lowest (b) 
concentration for the calibration of some 
Group B compounds.Conditions as in 
Figure 3.14.
Table 3.5. Statistical analysis of the calibration of some Group B compounds
(0.7-13 ug.rnl-1), using norpipanone as internal standard and peak area ratios. 
Conditions as in Figure 3.15.
Pethidine Benzphetamine Normethadone Methadone • Dipipanone
Correlation 0.999 0.9993 0.9996 0.9993 0.9984
Slope 0.0325 0.0742 0.098 0.0880 0.0804
Std. dev. 
of slope 0.0005 0.0014 0.0014 0.0016 0.0026
Intercept 0.0037 0.00089 -0.00009 -0.0052 0.0191
Std. dev. of 
intercept 0.005 0 . 0 1 2 0.0119 0.0136 0.024
Variance 0.044 0.1978 0.3451 , 0.2784 0.2623
Precision / — \ n = 4 n = 7 n = 7 n = 7 n = 7(n )
Mean (Peak 
area ratios) 0.3039 0.6973 0.9114 0.8173 0.7804
Standard
deviation 0.0044 0.00887 0.00791 0.00448 0.0368
Relative 
standard ' 1.45% 1.27% 0.87% 0.55% 4.7%
deviation

















Figure 3.16a Calibration of pethidine (0.7-18 yg.ml"1 ) with norpipanone
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Figure 3.16b Calibration of dipipanone (0.7-18 y g.ml”1 ) with norpipanone
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Figure 3.16c Calibration of benzphetamine (13), normethadone (15) and methadone
(16), (0.7-18 pg.ml 1 ) with norpipanone as internal standard.






3.2 Trimethyl silyl-bonded Silica
Hypersil SAS is a 5 pm material with a surface 
2 -1area of about 2 0 0  m g and a mean pore diameter of 1 2  
nm. It consists of an alkyl chain bonded by Si-C 
linkages to microspherical silica, i.e. it is a Cl 
material. This material was considered to be suitable 
for rapid chromatography of the solutes in this work 
because it has a low carbon loading, 2.6%. The main 
mechanism of retention of the amines on this stationary 
phase is influenced by the reversible association of 
the solute with the hydrocarbonaceous ligand of the 
stationary phase, and the hydrophobic properties of the 
solutes.
A 100 x 4.6 mm i.d. column was packed and its 
performance examined in the reversed phase mode, 
bearing in mind the possibility of its use with the 
post-column system. The longer column was chosen to 
provide more column efficiency (N).
3.2.1 Investigation of Chromatographic Conditions
Using Hypersil SAS
Chromatographic parameters were investigated to 
test the performance of this material with the ultimate 
aim of getting a short experimental time and good 
resolution.
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3.2.1a Influence of Mobile Phase pH
For Group A compounds it was decided to
chromatograph the solutes using the same conditions as 
with cyanopropyl-bonded silica. It was observed that 
the compounds were well retained and the retention 
times were longer than in cyano-bonded silica. Hence 
the effect of pH was examined. At the chosen pH range
(3 - 6.2) it was observed that pH 5.4 would be suitable
for Group A compounds whilst Group B compounds required 
a pH of 3.1. Figures 3.17 and 3.18 show the effect of 
pH on these two groups of compounds. Reduction in pH 
shows that the basic amines are forced to protonate 
more, thus making them more polar and therefore 
reducing the retention. No selectivity changes were 
observed as pH was varied.
3.2.1b Influence of Organic Modifiers
An important factor in reversed phase HPLC is 
the choice of an aqueous-organic solvent mixture that 
results in selective retention of solutes. It was 
therefore appropriate to investigate the ratio of 
methanol-acetonitrile required to separate a mixture of 
all Groups A and B compounds at their respective pH.
At a buffer pH of 5.4 and a constant 5% v/v 
acetonitrile, the percentage of methanol-acetonitrile 
mixture in the mobile phase was increased gradually up 
to 12.5% v/v each for Group A compounds. Figure 3.19
21
10
2.5 3.5 V, 5 5.5 6 .5
PH
.Figure 3.17 Influence of mobile phase pH on Group A compounds. Conditions -
Hypersil-SAS (100 x 4.6 mm i.d.). Column, mobile phase was 0.005 M 
phosphate buffer-methanol-acetonitrile (90:5:5, v/v/v) flow rate was 












Figure 3.18 Influence of mobile phase pH on Group B compounds, using Hypersil-SAS 




shows that solute retention decreased almost linearly, 
although the effect seems to be more on the compounds 
with methyl groups attached to the nitrogen atom. Group 
B compounds were also examined, and it was observed 
that they seem to follow the same pattern as in the 
cyano-propyl material, Figure 3.20 illustrates this. 
3.2.1c Influence of Buffer Concentration
The effect of buffer ionic concentrations on 
solute retention was examined over the range 0 . 0 1  M to 
0.1 M, using the respective pH and organic modifier 
composition pre-determined above. Solute retentions 
were decreased as buffer concentration was increased, 
in all cases. Figures 3.21 and 3.22 illustrate this.
The range 0.01 M to 0.1 M was chosen as a result of the 
high retention values obtained as compared to the 
previous results from the examination of these 
compounds on cyanopropyl bonded phase.
All the above conditions have been well 
explained in Section 3.1.2
Figures 3.23 and 3.24 show the chromatograms for 
Groups A and B respectively under conditions selected 
for minimum reproducible k' values.
The order of elution of these compounds are 
basically the same as with the cyano-propyl material 
except that mephentermine (8 ) and phendimetrazine (9 ) 
had interchanged positions in Group A while in Group B, 




















Figure 3.19 Influence of mobile phase methanol-acetonitrile (1:1) content on the retention of
group A compounds. Hypersil-SAS (100 x 4.6 mm i.d.) column, mobile phase was 0.005 M 
phosphate buffer (pH 5.4), flow rate, 1 ml.min-1, monitored at 205 nm and 0.04 a.u.f.s.
i—1
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Figure 3.20 Influence of mobile phase methanol-acetonitrile (1:1) content on the
retention of Group B compounds. Mobile phase pH 3.1. All other conditions






Figure 3.21 Influence of iaobile phase buffer ionic strength on the retention of
Group A compounds. Condition as in Fig. 3.17, but mobile phase pH
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Figure 3.22 Influence of mobile phase buffer ionic strength on the retention
of Group B compounds. Conditions as in Figure 3.18 but mobile phase 
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MINUTES
Figure 3.23 Chromatograms of Group A solutes. Conditions: 
5 ym Hypersil-SAS (100 x 4.6 mm i.d.) column 
with 0.02 M phosphate buffer (pH 5.4) - 
methanol - acetonitrile (90:5:5, v/v/v) 
at 30°C, 1 ml.min  ^ flow rate monitored 
at 205 nM and 0.02 a.u.f.s. Injection 
volume (20 yl) contained 5-15 ng of 
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Figure 3.24 Chromatograms of Group B solutes.
Conditions: 5 ym Hypersil-SAS (100 x 4.6 i.d.) 
column with 0.02 M phosphate buffer (pH 3.1)— 
propan-2-ol-acetonitrile (65: 17.5: 17.5, 
v/v/v), flow rate 1 ml.min  ^monitored at 
205 nm. Injection volume (10 yl) 
contained 10 ng each solute. Solute 
code as in Fig. 3.18.
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These are unexpected, and may well be as a result of . 
the morpholine group in phendimetrazine. The structure 
of piritramide is different from other compounds in 
this group and its behaviour is probably greatly 
influenced by the cyclic nitrogen-atom.
The long retention times obtained for all these 
compounds on Hypersil SAS was not expected and is 
probably not caused by interaction with free silanol 
groups either, because peak shapes (Fig. 3.23-24) were 
good, with peak asymmetry (As) in the range of 1.0-1.5 
(Table 6.1). The long retentions probably reflect the 
low content of organic modifier and the longer column 
length employed.
3.2.2 Quantitative Aspect
In view of the fact that good resolutions and 
selectivities were obtained with the above material 
under the chosen conditions, the system was then 
subjected to quantitative investigation with a 1 0 0  x
4.6 mm i.d. column using the conditions described in 
Figure 3.23, for Group A compounds. Five-point 
calibrations were made for a mixture containing 
dexamphetamine, methylamphetamine and three 
metabolites, namely p-hydroxynorephedrine, p-hydroxy- 
amphetamine and p-hydroxymethylamphetamine. Linear 
relationships between solute concentrations and peak 
areas were obtained over the concentration range 
10-80 yg.ml  ^with correlation coefficients in the 
range 0.998-0.999 and intercepts not significantly 
different from zero as shown in Table 3.6 and Figures 
3.25 and 3.26. Adaptability of the system was tested by 
packing a 1 0 0  mm x 2 mm i.d. column, and using the same 
conditions as for a 100 mm x 4.6 mm column except 
reducing the flow rate to 0.5 ml.min”'*'. Similar 
capacity factors were obtained when tested with Group B 
compounds. Sensitivity had increased about five times 
and column efficiency had improved to 3880 in 
dipipanone (Fig. 3.27) compared to 1520 in the 100 x
4.6 mm i.d. column.
Quantitative investigation was then repeated for 
some Group A compounds with the Hypersil SAS (100 x 2.1
Figure 3.25 Chromatograms of the highest (a) 
and lowest (b) concentrations for 
the calibration of p-hydroxynorephedrine 
(1 ), p-hydroxyamphetamine (2 ), p-hydroxy- 
methylamphetamine (3), dexamphetamine (5), 
methylamphetamine (7). Injection volume 
( 1 0  1 ) contained 10-80 ug.ml \
Conditions as in Fig. 3.23.
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Figure 3.26 Calibrations of some Group A compounds. Conditions and code
as in Figure 3,25.
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Table 3.6. Statistical analysis of the calibration of some Group A -compounds (10-80 p g .ml-^ ).
p-hydroxynorephedrine (1),p-hydroxyamphetamine (2), p-hydroxymethylamphetamine (3), 
dexamphetamine (5), methylamphetamine (7). Conditions as in Fig. 3.25.
1 2 3 5 7
Correlation coefficient 0.9997 0.9991 0.9997 0.9990 0.9999
Slope 3700.7 2709.3 3415.2 3844.2 3191.9
Std. dev. of slope 43.921 56.055 38.879 85 .287 3 .3379
Intercept -539.04 -4594.7 -4070 -8581 -3517.3
Std. dev. of intercept 2024.7 2584 179.2 3931 .5 153.87
RSD of slope (± , % ) 0.03 0.04 1.14 2 . 2 2 0 . 1 1
127
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mm i.d.) column in a concentration range of 
2-20 ug.ml"”^  using a Spectra Physis SP8100 liquid 
chromatograph with autosampler, oven and 2 0  yl sample 
loop, SP8440 UV-Vis detector and SP4200 computing 
integrator. Peak areas were used for the calibration 
here. Linear relationship was also obtained (Figure 
3.29) and correlation coefficients were between 0.991 
and 0.997 with small negative intercepts. Figure 3.28 
shows the highest and lowest concentrations for 
calibration.
Calibration of Group 3 compounds using the 
conditions in Figure 3.27 was also carried out over the 
concentration range of 1-4 ^g.ml  ^ for all the 
compounds. A linear relationship was obtained with 
correlation coefficients ranging from 0.995-0.999,
Table 3.8 shows the statistical analysis while Figures 
3.30(a) and 3.30(b) are the highest and lowest 
concentrations for calibration.
The results obtained are reproducible, both 
resolution and column efficiencies are acceptable. It 
shows this is a sensitive and versatile system.and it 
is very simple to operate. The only drawback could be 
the column life at pH 3.1 which is used for Group B 
compounds, and the very short alkyl chain which renders 






Figure 3 . 2 7 , Typical chromatograms of Group B 
compounds.
5 pm Hypersil-SAS (100 x 2.1 mm) column, 
flow rate 0.5 ml.min  ^ contained about 
3 ng each solute. All other conditions 
as in Figure 3.24.
Figure 3.28 Chromatograms of the highest (a)
and lowest (b) concentration for the 
calibration of p-hydroxynorephedrine 
(1 ), p-hydroxyamphetamine (2 ), 
p-hydroxymethylamphetamine (3), 
dexamphetamine 95) and methyl- 
amphetamine (7) (2-20 yg.ml-1). 
Conditions as in Figure 3.23
§
(except for flow rate 0.5 ml/min).
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Figure 3.29 Calibration of some Group A compounds. Conditions and
solutes as in Figure 3.28.
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Table 3.7. Statistical analysis of the calibration of some Group A- compounds (2-10 yg.ml ^).
p-hydorxynorephedrine (1 ), p-hydroxyamphetamine (2 ), p-hydroxymethylamphetamine 
(3), dexamphetamine (5), methylamphetamine (7). Conditions as in Figure 3.28.
1 2 3 5 7
Correlation coefficient 0.9910 0.9911 0.9915 0.9911 0.9913
Slope 4017. 9 t 2544.8 3427 .2 3457.1 3065 .5
Std. dev. of slope 221.33 138.98 183 .11 189.5 166.06
Intercept -2338.5 -1303.2 -1848.9 -1393.1 -1638.8
Std. dev. of intercept 2718 1706.7 2248.6 2327.1 ,2039.2
RSD of slope (±, % ) 5 .51 5.4 5.34 5.4 5.4
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Chromatogram of the highest concentration 
(4.0 ng.ml for the calibration 
of Group B compounds. Conditions and 
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Figure 3.30(b) Chromatogram of the lowest
concentration (1 . 0  pg.ml for the 
calibration of Group B compounds. 
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gure 3.3.1. Calibrations of Group B compounds. Conditions and code
Table 3.8. Statistical analysis of the calibration of Group B compounds, 
and solute code as in Figure 3.30.
Conditions
Correlation
1 1 1 2 13 14 18 15 16 17 19
coefficient 0.9958 0 .999 0.998 0.9993 0.9998 0 .9997 0.9962 0.9969 0 .994
Slope 
Std. dev. of
28.2 72.5 44 .7 25 .7 24.9 36.2 25 . 8 22 .7 15 . 6
slope 1.2961 0.592 1.4248 0.48 0 .265 0.42 1.13 0.17 0.85
Intercept 
Std. dev. of
-3.0 1 . 0 3.5 1.50
CMOO1 0.5 1 . 0 -0.5 -1 . 0
intercept 
RSD of
3.5496 1.62 3.902 1.31 0 .725 1.162 3.1 0.47 2 .32
slope 
(±, % )
4.59 0.82 3.19 1.87 1.06 1.16 4.38 0.75 5.45
136
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3.3 Ion-Exchange Bonded Silica
3.3.1 Nucleosil SA
Nucleosil SA is a silica-based cation exchanger 
that is strongly acidic. It is a spherical, totally 
porous material, stable between pH range 1-9. It has a 
constant permeability, even when the strength of the 
mobile phase ions vary and or when the pH value of the 
eluent is altered. The functional group is sulphonic 
acid, and the organic part is:
and particle size 5.0 ± 1.5 pm.
It is generally known that for ion exchangers, 
different ions show different degrees of affinity to 
the ion exchange sites, for example the order of 
increasing affinity for a cation exchanger is as 
follows:-
Divalent ions are more attracted to the ion exchange 
group than monovalent ions and trivalents more than 
divalents. The greater the strength and effective 
radius of the ions, the stronger the attraction to the 
ion exchange groups.
The primary process in cation exchange is 
adsorption-desorption of charged basic solutes with a
The pore diameter of this material is 10 njn,- the
pore volume is 1 . 0  ml.g  ^ with a specific surface area
2 - 1  -1 of 350 m .g and ion-exchange capacity of 1 mequiv.g
H+ < Na+ < NH.+ < C + < Ag+ 
<r S 3
138.
permanently charged anionic stationary phase. There are 
secondary mode effects inherent in ion exchangers, 
which are mainly adsorptive in nature. The suitability 
of this material to chromatograph compounds in Groups A 
and B was investigated. A 100 x 4.6 mm i.d. column was 
initially packed and tested, but due to very high 
retention values obtained, a 50 x 4.6 mm i.d. column 
was finally used for this work.
3.3.1a Influence of Mobile Phase pH
The study of the influence of pH on the retention
of Group A compounds was studied using 0.05 M phosphate 
buffer-methanol-acetonitrile (90:5:5, v/v/v). Retention 
of all solutes were reduced as pH was increased, but 
large capacity ratios were obtained even at a pH of 7.2.
A change in the pH value of the mobile phase 
will only alter the equilibrium between the sample 
molecules and the functional ionic groups of the 
stationary phase. When the pH of the system is
decreased, the protonated amines are formed more
readily:
RNH2 + H+ RWH3 ,
and therefore competition of the charged amine ions for 
the cation exchange sites are increased and subsequently 
retention is increased. It has been
139.
suggested that in cation exchange an increase in pH is 
equivalent to an increase in solvent strength, 
therefore a decrease in retention would be expected.
3.3.1b Influence of Organic Modifiers
The effect of increasing the quantity of 
organic modifier is similar to what was observed in the 
reversed phase system for cyanopropyl and Hypersil SAS 
columns. As solvent strength is increased retention was 
reduced almost linearly for these compounds.
3.3.1c Influence of Buffer Ionic Strength
The ionic strength of the mobile phase is 
proportional to the concentration of the ions in 
solution. Increasing the ionic strength at a constant 
pH caused a reduction in retention, this is because 
there is more competition for ion-exchange sites 
between the protonated solute and buffer ions.
Therefore retention was reduced. There were some 
selectivity changes, but in general they were small and 
not an important consideration.
It was decided -o use 0.2 M KH2 PO4 (pH 5.0)- 
methanol-acetonitrile (82.5: 10: 7.5, v/v/v) at 57°C 
with Group A compounds. This is because this condition 
gave a good resolution between the compounds and 
analysis time Was shor.. This condition gave 
good peak shapes that are comparable with the
140.
cyanopropyl column. Figures 3.32 and 3.33 show typical 
chromatograms of some Group A and Group B compounds, 
respectively.
3.3.2 Quantitative Aspect
The above condition was used for the calibration of 
some solutes in Group A over the concentration range of 
0.25-1.0 yg .ml Linear relationships were obtained
with correlation coefficients 0.999, and slope RSD 
± 5, Table 3.9).
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Figure 3.33. Chromatograms of the separation of Group 
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Figure 3.34. Chromatograms of the highest (a>*and
lowest (b) concentrations for the calibration 
of some Group A compounds. Conditions and 
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re 3.35. Calibration of some Group A compounds. Conditions as in
Figure 3.32. Solute codes as in Figure 3.1.
Table 3.9. Statistical analysis of the calibration of some Group A compounds,
p-hydroxynorephedrine (1), p-hydroxyamphetamine (2), dexamphetamine (5), 
methylamphetamine (7) and mephentermine (9). (0.25-1.0 yg.ml”^). 
Conditions as in Figure 3.32.
1 2 5 7 9
Correlation coefficient 0.9980 0.9921 0.9963 0.9995 0 .9941
Slope 16.8 22 .3 38.1 40.7 31.1
Std. dev. of slope 0.529 0.959 1.634 0.656 1.024
Intercept 0 . 0 0 0 2 1 . 0 -3.0 -0.5 -6 . 0
Std. dev. of in te rcep t 1.4491 9 .259 4 .475 1 .80 4 .64
RSD of slope (±, %) 3.15 4.48 4.29 1.61 3.29
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3.4 Other Chromatographic Materials Investigated 
3.4.1a PRP-1
This is a 10 urn porous polystyrene divinylbenzene 
polymer adsorbent material with physical and chemical 
properties very similar to those proposed for XAD-2, but 
PRP-1 has a higher surface area and is suitable for HPLC 
applications. Its major advantage is that it is stable 
over the pH range 1.5 to 13. Lee et_ al. (52) demonstrated 
the versatility of this material by using it to separate 
nucleosides and their corresponding bases at both low 
and high pH, but it was discovered that those bases 
had very short retention and separation efficiency.
A 150 x 4.1 mm commercial column with PRP-1 
material was tried with the same conditions used for 
Spherisorb-CN, Hypersil-SAS and Nucleosil SA, but the 
peak shapes were very broad with long retention times. 
Increasing organic modifier content to 36% (0.025 M 
citrate-phosphate buffer, pH 4, -propan-2-ol-acetonitrile, 
54; 18; 18% v/v/v) did not improve peak shapes adequately. 
The addition of 1% dichloromethane to the mobile phase 
has been shown (53) to double column efficiency when 
mainly aqueous mobile phases are used, however this 
did not improve column efficiency with the above mobile 
phase.
3.4.1b Hypersi1-Phenyl
This is a 5 Jim particle marketed principally as 
a reversed phase material for the separation of moderately
147.
polar materials. The carbon loading of this material is 
about double that of trimethylsilyl-bonded silica (5.0%), 
with phenyl as the functionality. This material would 
be more hydrophobic than the cyano-phase under reversed- 
phase conditions but less retentive than Cg materials.
It was selected because it was expected to be more stable 
than Hypersil SAS which has a short alkyl chain (C^) 
and therefore the silyl bonding is more exposed to 
attack by mobile phase.
A 100 x 2.1 mm i.d. column was packed as 
described in Section 2 and tested under the same conditions 
as Hypersil SAS, using Group A compounds. Peak shapes 
were poor and asymmetric even when organic modifier and 
buffer concentrations were increased. Work with this 
material was therefore discontinued.
The problem of peak tailing and excessive 
retention when basic compounds are chromatographed on 
octadecyl-silica materials has been overcome 
by the addition of amines, such as N,N-dimethylamino- 
octane to the mobile phase (54). This type of compound 
masks the acidic silanol groups responsible for the 
problem and is very effec-ive. Unfortunately this 
approach is not compatible with post-column ion-pair 
detection.
SECTION 4
DETERMINATION OF DISSOCIATION 
CONSTANTS (pKA) AND PARTITION 
COEFFICIENTS (Log P)
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SECTION 4. AN EXAMINATION OF THE EFFECTS OF THE MOBILE 
PHASE COMPOSITIONS OSED IN SECTION 3 UPON 
SOLUTE DISSOCIATION CONSTANT (pKa) AND 
PARTITION COEFFICIENT (log P)
4.1 Examination of the Dissociation Constants (pKa) 
of the compounds investigated
The basic nature of the drugs of abuse examined 
in this thesis is of interest, because it is difficult 
to define a simple physico-chemical reference state for 
such solutes for which dynamic (RP-HPLC) and static 
(e.g. octan-l-ol-water distribution, aqueous 
solubility) parameters are comparable (42).
Furthermore, various experimental procedures such as 
spectrophotometry, potentiometry and conductometry have 
been employed to generate pKa values.
The Bronsted-Lowry theory is the most useful and 
widely accepted description of the ionization of both 
acids and bases. The underlying concept of this theory 
is the definition of a base as a substance which can 
accept a hydrogen ion. The pKa of a compound is usually 
expressed as the negative logarithm (-log) of its acid 
dissociation constant. The pKa value is said to be a 
convenient numerical way to compare the relative 
acidity or basicity of ionising compounds in aqueous or 
miscible solvent-aqueous solutions (56, 57).
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The earlier investigation (Section 3) of the 
effect of mobile phase pH upon solute capacity ratio 
(Section 3.1.2a) showed that for all the solutes 
examined, capacity ratios continued to fall at pH 
values 0.6 to 2.8 pH units below literature (pKa - 2) 
values. It was anticipated that minimum k' values would 
be obtained, but even at a pH of 4.0 minimum k' values 
had not been reached for solutes whose literature ?Ka 
values ranged from 6 . 6  to 10.4. It was therefore 
decided to examine the effect that the mobile phase had 
upon the determination of pKa values and to compare 
these with literature values.
4.1.1 EXPERIMENTAL PROCEDURES
Potentiometric titration was used according to 
the procedure described by Albert and Serjeant (58), 
and is described in Section 2.6. The performance of the 
equipment and procedure was tested using sodium 
benzoate as recommended by Albert and Serjeant and the 
results obtained are compared in Table 4.1 with those 
given by ref. 58.
The following equation was used to calculate the pKa 
values of the bases determined in this work:
pKa = pH + log [BH+ ] - log [B] .4.1a
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Table 4.1. The determination of the pKa of sodium 
benzoate at 20°C






0 6.40 - -
0.5 5.05 4.10 4.14
1.0 4.70 4.10 4.15
1.5 4.50 4.13 4.16
2.0 4.30 4.12 4.16
2.5 4.18 4.08 4.15
3.0 3.95 4.11 4.15
3.5 3,80 4.14 4.16
4.0 3.58 4.12 4.16
4.5 3.30 4.08 4.15
5.0 3.10 - -
The average pKa from this experiment is 
4.11 ± 0.03 which is comparable to the literature value 
of 4.15 ± 0.01. It was therefore considered that the 
apparatus and procedure was sufficiently accurate for 
pKa determinations.
The dissociation of a weak base may be taken
as: -
BH+ + H20 H30+ + B ...4.1b
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K = ___±_______  ...4.2
a  > r -i
a^BH+ ^
where, Ka = thermodynamic dissociation constant
a„ = thermodynamic activity of hydrated
3
proton
aD = thermodynamic activity of
D
undissociated base 
an.„+ = thermodynamic activity of cation.
The thermodynamic activities are used in order to allow 
for the departure from ideality of real solutions, and 
the thermodynamic dissociation constant is independent 
of the concentration. In all determinations in this 
study, activity corrections were made where necessary. 
The pKa values for nineteen compounds were determined 
using eight different solvent compositions chosen to 
examine the effect of HPLC mobile phase composition and 
are given in Table 4.2.
4.1.2 RESULTS OF pKa DETERMINATIONS IN VARIOUS 
SOLVENT COMPOSITIONS
The pKa values for all the solutes studied in 
Section 3 were determined under the conditions given in 
Table 4.2 and the results are presented in Tables 4.3 
to 4.4.















Ethanol-Water (50; 50% v/v) at 20°C 
Ethanol-Water (50; 50% v/v) at 40°C 
Ethanol-0.02 M KC1 solution (50; 50% v/v) 
at 20°C
0.02 M KC1 solution at 20°C 
0.02 M KCl solution at 40°C
•k
0.02 M KCl solution - Organic modifier 
(90; 10% v/v) (Group A Compounds) at 20°C 
n n " a t  40 °C
0.02 M KCl solution - Organic modifier 
(65; 35% v/v) (Group B compounds) at 20°C
at 40°C
Phosphate buffer (pH 5.4) - Organic 
modifier* (90; 10% v/v) (Group A 
compounds) at 30°C
Phosphate buffer (pH 4.1) - Organic 
modifier** (65; 35% v/v) (Group B compounds) 
at 40°C
Ace-onitrile-Methanol (50;v50% v/v) 
Aceronitrile-Propan-2-ol (50; 50% v/v).




Lit Values 1 2




p-OH-Norephedrlne 9.29±0.02 8.18±0.01 7.62±0.02 9.25±0.05 8.51±0.04 9.3410.01 9.1810.03 8. 801 0.04
p-OH-Amphetamlne 9.30 9.32±0.05 8.22±0.03 7.91±0.03 9.30+0.01 8.62±0.01 9.4110.04 9.2110.03 8.8510.02
p-OH-N-Methylamphetamine 9.55±0.01 8.41±0.03 8.22±0.05 9.4510.02 8.80±0.03 9.8010.01 9.2810.02 9.0110.02
2-Phenylethylamine 9.83(5?) 9.72±0.01 8.57 ±0.04 8.35±0.01 9.61±0.04 9.0110.02 9.8510.05 9.3610.01 9.12+0.01
Dexamphetamine 9.90 9.88±0.02 8.72±0.01 8.41±0.03 9.82+0.01 9.2510.01 9.9610.01 9.4110.01 9.2510.03
Methylamphetamine 10.10 10.05±0.02 9.01±0.05 8.62±0.1 9.96±0.06 9.4210.03 10.2110.02 9.7010.01 9.410.01
Phenmetrazine 8.40 8.41±0.03 7.50±0.02 6.90±0.03 8.43±0.01 7.7110.04 8.5410.01 7.86±0.04 7.2010.05
Phendimetrazine 7.60 7.65±0.05 6.71±0.03 6.25±0.01 7.7010.02 6.9510.01 7.91±0.03 7.33±0.02 6.5210.03
Mephentermine 10.40 10.51±0.03 9.32±0.08 8.95±0.02 10.4810.01 9.7310.01 10.4810.04 9.75±0.01 9.81+0.03
Chiorphentermine 9.60 9.74+0.02 8.64±0.04 8.10±0.01 9.7010.05 8.97+0.04 10.1510.03 9.39±0.01 10.0210.01
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Lit Values 1 2
pKa found
3




Pethidine HC1 8.70 8.40±0.01 6.90±0.01 7.75±0.02 8.80±0.01 8.00±0.06 8.10+0.02 8.05±0.05 7.00+0.05
Pipradrol 9.71 9.69±0.04 8.21±0.04 8.43±0.05 9.30±0.03 7.73±0.03 9.90+0.05 9.76±0.04 8.50±0.04
Benzphetamine 6.60 6.71±0.03 5.43±0.05 6.03±0.04 6.51±0.02 5.06±0.02 7.14+0.04 6.83±0.06 5.70±0.05
Normethadone 9.20 8.75±0.04 8.11±0.06 8.24±0.02 8.80±0.03 7.00±0.06 9.12±0.05 9.01±0.05 8.02±0.10
Fentanyl Citrate 7.34 7.35±0.01 7.04±0.03 5.75±0.03 4.75±0.05 4.91±0.08 5.78±0.04 5.60±0.15 3.70±0.05
Methadone 8.25-9.64 9.16±0.01 8.05±0.05 9.00±0.06 9.08±0.01 7.81±0.01 9.50±0.04 9.40±0.03 8.15+0.06
Piritramide 8.50 9.01±0.03 7.51±0.04 8.00±0.02 8.92±0.01 7.40+0.05 9.29±0.02 9.23±0.06 8.18+0.04
Norpipanone HC1 8.50 9.02±0.01 8.00±0.02 8.10±0.01 9.00±0.04 7.20±0.03 9.24±0.05 9.18±0.07 8.22±0.06




4.1.3a Influence of Temperature on pKa
The effect of temperature on the pKa of organic 
bases has been investigated by different workers, and 
nitrogenous bases are said to be highly temperature 
sensitive (58-60).
Perrin proposed a general equation governing the 
temperature variation for the ionization of a base or 
- an acid as:
d(pKa) _ pKa AS° _ pKa+0. 218AS° ...4.3
dT T 2.303RT T
and for monoacidic bases the equation becomes:-
d(pKa) _ pKa - 0.9 ...4.4
dT T
where; R = Universal Gas Constant
T = absolute temperature (°K)
AS^ = entropy change
In this work, pKa has been determined at 20°C
and 40°C. Table 4.2, because these were the
temperatures used for chromatographic analysis.
Equation 4.4 has been used to predict pKas at 40°C and 
plots of predicted pKa versus experimental pKa at 40°C 
under different solvent conditions are given in Figures 









Fig. 4.1. Group A compounds in ethanol-water 
















Fig. 4.3. Group A compounds in 0.02 M KCl-methanol 














Fig- 4.4. Group B compounds in Ethanol-Water 






































Fig. 4.6. Group B compounds in Phosphate buffer -
propan-2-ol - acetonitrile (65; 17.5; 17.5 
v/v/v) at 40°C
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between analyte pKa and temperature is a linear one 
(r = 0.9186 to 0,9988) and that the relationships are
similar for the solvent conditions examined (slopes = 
0.8885 to 1.0663). '
An examination of the rate of pKa change per °C
dpKa
temperature change ( dT ) for each compound is given in
Table 4.5a. This shows that all the compounds give a
pKa decrease with an increase in temperature, as
reported by previous workers (58, 59), and that the
rates of pKa decrease per °C are generally between 0.02
and 0.03. Among Group A compounds, phendimetrazine has
the lowest pKa in each of the conditions, followed by
dpKa
phenmetrazine, also the dT values are low namely 
0.0230 and 0.0256 respectively. An examination of their 
structures (Figure 2.IB) shows that they both’have 
cyclic nitrogen and cyclic oxygen (morpholine group) 
which make them weaker bases than other members of the
group. Fentanyl citrate in Group B seems not to have
any consistent behaviour under these experimental 
conditions, and has been excluded from the statistical 
calculations above. From its structure (Figure 2.IB) 
one would expect it to have two pKa values.
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Table 4.5a. Rate of analyte pKa change with





4 and 5 6 and 7
p-OH-Norephedrine 0.0286 0.0285 0.0288
p-OH-Amphetamine 0.0287 0.0287 0.0290
p-OH-N-Methylamphetamine 0.0295 0.0292 0.0304
2-Phenylethylamine 0.0301 0.0297 0.0305
Dexamphetamine 0.0306 0.0304 0.0309
Methylamphetamine 0.0312 0.0309 0.0318
Phenmetrazine 0.0256 0.0257 0.0261
Phendimetrazine 0.0230 0.0232 0.0239
Mephentermine 0.0328 0.0327 0.0327




4 and 5 8 and 9
Pethidine 0.0260 0.0270 0.0246
Pipradrol 0.0300 0.0287 0.0307
Benzphetamine 0.0198 0.0191 0.0213
Normethadone 0.0268 0.0270 0.0281
Fentanyl 0.0220 0.0131 0.0167
Methadone 0.0282 0.0279 0.0294
Piritramide 0.0277 0.0274 0.0286
Norpipanone 0.0277 0.0276 0.0285
Dipipanone 0.0280 0.0278 0.0289
For a description of the conditions used, see 
Table 4.2.
Table 4.5b. Average rate of analyte pKa change with 
' temperature
Conditions:







1 and 2 4 and 5 8 and 9
B:
Mean 0.0262 0.0250 0.0263
Standard deviation 0.00326 0.0053 0.0046
Overall Mean (Groups A &  B) = 0.0267
Relative Standard Deviation = 7.10%
Comparison of the means obtained under identical 
conditions shows that Groups A and B behave similarly. 
Comparison of the means obtained under different 
conditions are also similar, so that an average value 
for the dependence of pKa upon temperature has been 
calculated (Table 4.5b). The figure of 0.027 represents 
the average fall in pKa value per °C rise for the 
nineteen compounds examined here, and could be a useful 
guide when considering chromatographic optimisation.
In an attempt to explaim more accurately the 
effect of temperature upon pKa, the results in Table 
4.5 were used to calculate AS° values using equation
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4.3, and then an average AS0 value obtained which could 
be used to predict dpKa. This approach failed for all 
the results in Table 4.5, except for Group A compounds 
under Conditions 1 and 2, for which the relevant data 
is given in Table 4.6. Even here, the correlation 
coefficient between predicted dpKa and experimental 
dpKa was only 0.8160 and so this is not a satisfactory 
approach. This is probably because the a S° values are 
dependent upon the solvent compositions in which they 
are determined, and should be determined experi­
mentally. This was the approach used by Perrin (60), 
who averaged the experimental data from twelve 
compounds (range -8.1 to 1.7) to obtain the figure of 
-0.9 used in equation 4.3.
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Table 4.6. Calculated entropy change (a s 0 ) for Group A 
compounds
COMPOUNDS AS°calc d?Kacalc dpKaexpt
p-OH-Norephedrine 31.97 1.07 1.11
p-OH-Amphetamine 31.17 1.08 1.10
p-OH-K-Methylamphetamine 32.80 1.09 1.14
2-Phenylethylamine 32.69 1.11 1.15
Dexamphetamine 32.63 1.12 1.16
Methylamphetamine 23.79 1.13 1.04
Phenmetrazine 22.58 1.02 0.91
Phendimetrazine 28.08 0.96 0.94
Mephentermine 31.76 1.16 1.19
Chlorphentermine 29.24 1.07 1.10
Averace AS° n = calc 29.67
4.1.3fc Influence of organic solvents on pKa
Although it is desirable to measure dissociation 
constants in pure water, this is often not employed 
either because the compounds are poorly soluble in 
water or because other solvents are more appropriate to 
other studies, e.g. pharmaceutical formulation. In this 
work water and ethanol have been used as typical
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solvents for pKa determinations whilst methanol, 
propan-2-ol and acetonitrile have been included in 
volumetric proportions that have been chosen for 
chromatographic reasons. An examination of some of the 
properties of these solvents that could affect the 
dissociation of a compound are shown in Table 4.7.












Since alcohols and water contain an -OH group, 
they have many properties in common. Water is a very 
remarkable substance and one of its important 
properties is self-ionization:-
H20 + H20 H30+ + OH_ ...4.5
In pure water, the concentrations of H^O* and OH" are 
-7 -1low, only 10 mole L . Alcohols also undergo self­
dissociation, but not to the same extent as water, so
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that for methanol, the ion product
2CH3OH ^ CH3OH2+ + CH30" . ...4.6
is only 1.2 x 10~12 M2 whilst that of water is 1.0 x 
-14 210 M . The reduced value for alcohols are due 
largely to their dielectric constants (61) compared to 
water, i.e. it takes more energy to separate ions in 
alcohols, in other words, as the dielectric constant is 
reduced, the electrostatic interactions between ions 
increase (62). This phenomenon can be explained by 
applying Coulomb's law of electrostatic force expressed 
in terms of the work required to separate two ions of 
opposite sign in the medium (59).
i
Work is expressed as — -  ... 4.7
where, e = 4.8 x 10 ^  electrostatic units
—8r = distance between charges (2 x 10 cm) 
and e = dielectric constant
If we therefore calculate the work necessary to
separate ions in water and in methanol, we obtain
-13 -13
values of 1.4 x 10 erg and 3.49 x 10 erg
respectively. This means that for organic acids, pKa
values will be increased, whilst for organic bases, pKa
values will be reduced in methanol compared to water.
This effect would also apply to other solvents,
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including those in Table 4.7. Data taken from Tables 
4.3 and 4.4 confirms this for the effect of ethanol and 
is shown in Table 4.8. The dielectric constant of a 
mixture of solvents is calculated from the sum of the 
volume ratios of the dielectric constants of the 
individual solvent components (63), this effect is 
shown in Table 4.8. The dielectric constant values in 
Table 4.8 confirms that the effect of ethanol would be 
to reduce pKa values.
Table 4.8. Effect of dielectric constant of a mixture of solvents on pKa
COMPOUNDS
4

























* Dielectric constant of KCl solution is assumed to be the same as that of 
water.
Table 4.9. Effect of temperature on pKa
COMPOUNDS pKa pKa pKa pKa pKa pKa
(20°C) (40 °C) (20 °C) (40°C) (20°C) (40 °C)
♦CONDITIONS (1) (2) (3) (4) (5) (6). (7)
p-OH-Norephedrine 9.29 8.18 9.25 8.51 9.34 9.18
p-OH-Amphetamine 9.32 8.22 9.30 8.62 9.41 9.21
p-OH-N-Methylamphetamine 9.55 8.41 9.45 8.80 9.80 9.28
2-Phenylethylamine 9.72 8.57 9.61 9.01 9.85 9.36
Dexamphetamine 9.88 8.72 9.82 9.25 9.96 9.41
Methylamphetamine 10.05 9.01 9.96 9.42 10.21 9.70
Phenmetrazine 8.41 7.50 8.43 7.71 8.54 7.86
Phendimetrazine 7.65 6.71 7.70 6.95 7.91 7.33
Mephentermirie 10.51 9.32 10.48 9.73 10.48 9.75
Chlorphenetermine 9.74 8.64 9.70 8.97 10.15 9.39
* For Conditions Refer to Table 4.2.
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The effect of temperature on dielectric 
constants is to reduce their values as temperature 
increases (40), so that the organic solvent effect on 
pKa is enhanced as temperature is increased. This can 
be seen also in Table 4.9.
• 4.1.3c Effect of potassium chloride on pKa
Potassium chloride is sometimes used as an 
indifferent electrolyte. Any electrolyte in aqueous 
phase will dissociate and be randomly scattered in the 
organic solute. Protonation of an organic base by H^O+ 
will be hindered due to the presence of inorganic 
anions, therefore more H^O+ is required to overcome 
their effect i.e. a lower pH is required to protonate 
the organic base, and thus pKa is reduced. This is 
demonstrated in the results obtained in this work which 
are shown in Table 4.10.
It is interesting to note that 50% v/v 0.02 M 
KCl has approximately the same effect on ionization 
constants as 50% ethanol, especially for Group A 
compounds in this work.
Table 4.10. Effect of potassium chloride on pKa
Ethanol-Water 
(50? 50% v/v) 
pKa (20°C)
Ethanol-0.02 M KCl 





















4.2 Examination of the Partition Coefficient (log P)
of the Compounds Investigated
The partition coefficient of a solute is a 
measure of its distribution between two immiscible 
liquid phases (40, 64), most commonly n-octanol and 
water. It is also a measure of solute lipo'philicity, 
which is an important property of any drug substance 
because of its influence on solute biological 
properties.
The influence of a drug substance can only be 
obtained if it can reach the active site by a transfer 
process that involves passage through both hydrophilic 
and lipophilic barriers in the biological system. 
Therefore, the hydrophobic character of drugs is very 
important in drug design. Experimentally, log P values 
are determined under aqueous conditions which ensure 
that the compound, if it is an ionisable.compound, is 
fully non-ionised. However care is required in the 
selection of literature log P values because this is 
not always the case.
In reversed-phase HPLC, retention of a solute is 
described mainly as a function of its solvophobic 
interaction between an aqueous-organic mobile phase and 
a non-p.olar stationary phase (33, 44-47). This is 
essentially the same as the partitioning interaction 
between water and an immiscible organic solvent such as 
n-octanol. Although solute retention mechanisms may be
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complex and varied, it is a fact that in RP-HPLC solute 
retention can be correlated to their n-octanol-water 
partition coefficients. Attempts have been made to 
obtain substituent constants, for various functional 
groups (65—67), and this approach to the calculation of 
log P values for solutes, in general, is very useful.
However, an examination of literature 
experimental log P values indicates that considerable 
care is required in the selection of values. Table 4.11 
illustrates the variation in log P values quoted for a 
single compound, pethidine, (literature pKa = 8.7 at 
20°C) when measured at slightly different pH values.
All these values were obtained by the same author.
An examination of the Database (68) for log P 
values showed that for most of the compounds under 
examination in this study, values were not available.
It was therefore considered appropriate to 
experimentally determine these values, and in 
particular to determine them in the chromatographic 
mobile phases that had been optimised in Section 3, 
because Table 4.11 clearly shows the importance of 
aqueous phase composition.
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Table 4.11. Variation in experimental log P values for 
pethidine, for water-n-octanol, from 
ref. 4.13
Aqueous conditions given by author log P
pH 7.1 1.30
pH 7.4, phosphate buffer, 
not ion-corrected 1.59
pH 7.5, phosphate buffer, not 
ion-corrected 1.68
pH 7.6, where 2N in side chain, some 
di-protonation probable 1.77
pH 7.7, not ion-corrected 1.86
pH 7.7, ion-corrected 2.72
4.2.1 EXPERIMENTAL
The method used in this work is that described 
by Leo et al. (69), but using our own chromatographic 
mobile phases as described in Section 2.7 as the 
aqueous phase. The performance of this method and 
equipment was tested using fentanyl citrate at room 
temperature (21°C) and pH 7.4. An average value of 2.36 
(n = 2) was obtained which compared favourably with the 
literature value of 2.30 at pH 7.4 (66). The method was 
therefore used for all the compounds in this thesis and 
the results are given in Table 4.12.
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These values are greatly influenced both by the 
pH of the aqueous phase and the presence of organic 
solvents as chromatographic modifiers. For Group A 
compounds the conditions were 0.02 M phosphate buffer
pH 5.4 - methanol-acetonitrile (90; 5; 5% v/v/v) whilst
Y
for Group B compounds the conditions were 0.02 M 
phosphate buffer, pH 4.1 - propan-2-ol-acetonitrile 
(65; 17.5; 17.5% v/v/v). The influence of pH can be 
incorporated into partition coefficient determinations 
by using the Apparent Partition Coefficient (Papp) 
where Papp = P.Mn ...4.8
where Mn = fraction of molecules present in the 
non-ionised form.
For a monoacidic base,




app [1 + 10pKa"pH]
It is assumed that solute ions are not extracted into 
the solvent layer. However, . this equation would need 
further modification in order to take into account the 
presence of chromatographic modifiers.
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4.3 Relationships between hydrophobic parameters 
(log P), dissociation constants (pKa) and 
solute capacity ratios (k ')
The purpose of determining log P and pKa values 
in chromatographic mobile phases was in order to make 
better predictions of solute retention. Using the data 
obtained, attempts were made to find correlations 
""wherever possible.
4.3.1 RELATIONSHIP BETWEEN EXPERIMENTAL LOG P AND 
LOG k'
Since the experimental log P values were 
determined in the chromatographic mobile phases, it was 
anticipated that a relationship with solute retention 
should be observed. Fig. 4.7 shows that for Group B 
compounds a linear relationship was observed, 
r = 0.988, n = 7, but no similar relationship was found 
for Group A compounds. The reasons for this are not 
understood.
4.3.2 RELATIONSHIP BETWEEN EXPERIMENTAL k' AND 
PREDICTED k'
In the work of Hafkenscheid and Tomlinson (42), 
a description of the relationship between the retention 
of basic solutes and the mobile phase pH was 







Fig. 4.7. Relationship between log P and








Fig. 4.8. Relationship between experimental
K' and predicted k' of Group B compounds
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x + 10(pKa-pH)mobj-lBko+|1+10(pH-pKa)mobj-lB k+
...4.11
= non-logarithmic capacity factor of the 
chromatographed species, be it the 
solute, its uncharged form or its 
monoprotic charged form 
= solute pKa under mobile phase condition 
= mobile phase pH 
= mobile phase
= capacity factor in uncharged form 
= capacity factor in charged form.
This equation was applied to calculate k° and 
consequently predict k' at the different experimental 
pHs of 5.6, 6.2 and 6.8. A relationship was then sought 
between predicted k 1 and experimental k'. This is 
expressed in Figure 4.8. A correlation coefficient of 
0.9819, n = 21 was obtained, only about three or four 
points could be considered as outliers.
4.3.3 CONCLUSIONS
The results obtained in the determination of 
pKa suggest that under experimental conditions used for 
the chromatographic analysis of Groups A and B 
compounds in this work, pKa values are lower than 








-0.768 (range -0.45 to -1.20) and for Group B (n = 8) a 
mean value of -0.735 (range -0.10 to -1.70) were 
obtained. For Groups A and B, the mean reduction in pKa 
value was -0.75.
As expressed in Section 4.1, the experimental pKa 
values obtained are not adequate to explain the 
continuous fall in capacity ratios of these compounds 
at pH below 4.0. It would appear that other factors 
apart from the interaction of the protonated solutes 
with the bonded phases are responsible for any further 
retention of the solutes below pH 4.0.
H e r  (130) had pointed out that basic to the 
adsorption or exchange of cations on silica is the 
degree of ionization of the SiOH groups on the surface. 
The pKa of these SiOH groups varies from 6.5 at 0% 
neutralisation to about 9.2 at 50% neutralisation. 
Complete ionization occurs only at the pH just short of 
the point where silica dissolves and then only in the 
presence of a strong salt solution.
Mant e_t al. (131) have monitored free silanols on 
reversed-phase supports using peptide standards and 
found considerable differences between commercial 
silicas when monitored at pHs 2, 4.5 and 7. In general 
they consider a pH of 2.0 is required to suppress 
silanol ionization to minimise ionic interaction with 
basic peptide residues, but that this pH does not 
necessarily eliminate silanol effects because it 
depends upon the type of silica used. Silanols are
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negatively charged above pH 3.5 - 4.0, resulting in 
strong ionic interactions with basic peptide residues.
The interactions between protonated amines in 
this study and the free silanol group of the 
chromatographic packing materials used in this work is 
analogous to the interactions described by Mant et al. 
This is evident when Figures 3.1 and 3.2 are compared. 
It is noted in Figure 3.1 that capacity ratios are 
still falling steeply at a pH of 5.6 while in Figure
3.2 at pH 4.0 capacity ratios are more or less 
levelling out. Also in Figure 3.18 with pH 3-4, 
capacity ratios have almost levelled out. ,
In theory, one would expect the fall in k' values 
with reduction in mobile phase pH to reflect the 
increase in protonation of a base with fall in pH, i.e. 
a titration curve.
The effect of organic modifiers, buffer salts, 
and an increase in temperature all contribute to a 
lowering of pKa values for basic compounds, which for 
any particular mobile phase pH, means that retention is 






Figure 4.9. Influence of mobile phase components and pH 
on retention of basic drugs of abuse using 
silica-based reversed phase H.P.L.C.
a •
increase i n k 1 due to silanol effects
increase in k 1 due to chromatographic conditions
theoretical k' for basic compounds, according 
to % protonation
Mean solute literature pKa (n=15)
.
Mean solute experimental pKa (n=15) in 
chromatographic phases
Nominal increase in k 1 (« to solute log P) 
caused by change in pKa
Experimental average fall in pKa (-0.75)
The fall in retention with pH does not follow the 
new titration curve however because ionisation of 
silanol groups above pH 3.5-4.0 is significant, and its 
effect is to increase solute retention due to ionic 
interactions. Figure 3.18 shows that for Hypersil-SAS, 
solute retentions had not reached minimum values at pH 
= 3.0, so that even when silanol ionisation is minimal 
then other effects, such as hydrogen bonding may still 





SECTION 5 POST-COLUMN PERIVATIZATION
For the majority of analyses optimization of the 
chromatographic separation process is generally more 
important than the method of detection. However for 
those compounds having weak UV absorptivity, the 
problem of how to achieve adequate detection becomes 
the major concern, especially when the concentration 
levels expected in plasma are in the ng.ml 1 range.
The chemical derivatisation of analytes to enhance 
detection is not new and has been used for classical UV 
spectrophotometry and fluorescence so that its 
application to liquid chromatography was a logical 
step. A number of publications have provided 
information on both pre- and post-column derivatization 
coupled with HPLC (2, 70-83). Pre-column reactions were 
examined for their possible modification to a 
post-column system.
UV spectrophotometry, fluorescence and 
electrochemical detection were considered as possibly 
suitable for the organic amines in this study. 
Electrochemical detection was considered because HPLC 
assays have been described for narcotics (84, 85) and 
p-hydroxyamphetamine in mouse brain (86). Detection was 
achieved in each case by oxidation of a phenolic 
hydroxyl group. This would be suitable for some
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metabolites examined in this study but not for most of 
the analytes. Unfortunately, the detection of tertiary 
amines (87) has been reported to require a pH > 10, 
which means that silica based column materials could 
not be used especially if the mobile phase also needed 
to be mainly aqueous. The use of polymeric column 
materials would overcome the pH problem, but could not 
provide efficient chromatography using predominantly 
aqueous mobile phases. It is possible that a 
post-column addition of alkali to raise eluent pH 
followed by electrochemical detection might provide a 
suitable method for primary, secondary and tertiary 
amines, but this would require a great deal of study 
and was not examined experimentally.
Ultraviolet spectrophotometry and fluorescence have 
frequently been described for pre- and post-column 
systems and much attention has been given to primary 
and secondary amines. However almost half of the 
analytes considered in this study are tertiary amines 
and cannot be derivatized by any of these reagents.
Reports describing procedures for tertiary amines 
are very infrequent, although Kudoh et al. (88) 
developed a post-column system using acetic anhydride 
in citric acid to produce a red colour specific for 
tertiary amines. However the chromatographic 
selectivity was poor, tridecylamine and tridodecylamine 
were not resolved, the chromatographic conditions were
183.
normal phase, moisture reduced the colour produced and 
the post-column reaction needed a temperature of 120°C.
It was decided that ion-pair formation would be the 
most suitable initial approach to enhanced detection in 
a post-column system^ because:
a) All amines, when protonated, readily form ion-pairs 
with suitable reagents,
b) ion-pair formation is almost instantaneous and 
occurs at room temperature, so that adverse effects 
upon the analyte bands eluting from the HPLC column 
would be minimal.
Post-column derivatization systems have some 
advantages over pre-column derivatization methods, 
because in the post-column situation, the conditions of 
the reaction, (time, temperature, environment) are 
closely controlled by the dimensions and configuration 
of the equipment, so that the derivatization can be 
highly reproducible. Furthermore, it is not necessary 
for the reaction to go to completion. Time saved on 
sample preparation can be used to increase sample 
throughput. The most important disadvantage of 
post-column systems is the additional cost and 
complexity of the instrumentation.
Derivatization reactions are carried out in the 
post-column mode by the addition of reagents to the 
eluent from the HPLC column either by segmented flow 
analysis (SFA) or flow injection analysis (FIA). These
techniques have been adequately summarized (89-104) and 
their relative merits have been debated (105-109). Even 
though both employ similar chemical reactions, to give 
detectable end products, they differ in the 'mechanics' 
of sampling and use different approaches to achieve 
suitable precision and accuracy. Segmented flow 
injection analysis is potentially more sensitive than 
non-segmented and therefore has generated much interest 
recently. Primarily, it is the small sample volume, the 
low reagent consumption (110) and the high sampling 
frequency that attracts analytical chemists. Since 
extraction is widely used in pharmaceutical and 
clinical analysis to separate drugs or drug 
metabolites, it was logical to attempt to apply this 
principle as a post-column step to this study. The aim 
being to achieve better economy of extraction method 
with respect to time and solvent consumption.
All post-column reactors are continuous-flow 
devices (5). An ideal post-column reactor should be 
designed to permit chemical reactions to be performed 
reproducibly, carried far enough to completion for 
sensitivity, and yet, introduce little extra column 
band-broadening. Because of diffusion processes that 
occur in fluid solution, all designs introduce some 
measure of band broadening. This is largely due to 
laminar flow and the interaction of the fluid stream 
with the walls of the reactor tubing.
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Common reactor types are:
a) Tubular reactor - This is the simplest form of 
reactor consisting of an open-tubular system in 
which the post-column reagents are pumped into the 
eluate stream, mixed in a low-volume tee, and 
reacted in a coil of appropriate length and 
diameter, typically as described by Deeler and 
co-workers (111) .
b) Bed reactor - This can be a packed chromatographic 
column that operates under zero retention 
characteristics. It has been suggested by Hilby 
(112), that band broadening can be minimized by 
using columns packed with very small particles, 
such as glass (Balotini) beads (0.15-0.2 mm).
c) Segmented Stream Reactor - Here the flowing stream 
is a tubular system segmented with uniformly spaced 
air bubbles or with an immiscible solvent so that 
analyte dispersion is considerably reduced. 
Post-column chemistry is a very important part of
the post-column derivatization process. The chemistry 
can be very simple, for example a 0.5 pH change 
(113-115) can be sufficient for the reaction. In this 
case a simple open-tubular reactor with a short path 
length is sufficient, since reagents need only to be 
mixed. A segmented stream reactor permits the use of a 
wider range of reagents to the HPLC eluent, and depends 
upon the derivatized analyte being extracted into an
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immiscible organic solvent phase leaving the reagents 
in the HPLC eluent. This is essential in order to avoid 
massive UV or fluorescent background signals 
overloading the detector.
The success or failure of this approach depends 
upon the availability of a continuous flow aqueous- 
organic solvent phase separator, and its efficiency in 
providing to the detector a supply of organic solvent 
that is completely free of water droplets. At the time 
of this study no phase separator designed for the low 
flowrates employed in HPLC was commercially available, 
and publications described either modifications to the 
Technicon separator (120) which was designed for 
automated amino acid analysers, or described various 
in-house designs. A separator made by Kinkel and 
Tomlinson (5) was kindly loaned for testing and then a 
copy made at Bath University. This design was later 
modified by Dr. T.M. Jefferies in order to improve its 
performance at higher flowrates. Both separators have 
been described in Section 2.
5.1 INVESTIGATION OF THE PERFORMANCE OF TWO PHASE
SEPARATORS
Both separators were tested for their ability to 
supply to the UV detector a continuous flow of 
chloroform-pentan-l-ol (90:10; % v/v) that was totally 
free from water droplets. The aqueous phase was the
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HPLC eluent developed for Group A compounds using a 
Hypersil SAS column, namely methanol-acetonitrile- 
0.025 M aqueous phosphate buffer, pH 5.4 (5; 5; 90;% 
v/v/v). The organic solvent - aqueous phase volume 
ratio was maintained at (2:1) and the flowrates 
increased to determine the maximum flowrate at which 
clean organic solvent could be delivered to the UV 
cell. The results are summarised in Fig. 5.1.
The original phase separator (PSI, Fig. 2.7) had a 
single channel (1 x 1 x 17 mm) cut into the glass and 
PTFE blocks so that they coincided exactly. The major 
aqueous and organic outlets were situated in a small 
semi-circular chamber (2 mm radius) cut in each 
channel. Beyond the combined circular chamber, a single 
channel outlet permitted excess water and organic 
solvent to be pulled through the separator, improving 
the flowrate. Fig. 5.1 shows that the proportion of 
clean organic solvent to the UV cell rose to a maximum 
of 60% at a total organic flowrate of 1.5 ml min”1 . 
Above this flowrate droplets of water also entered the 
UV cell producing an unacceptably noisy baseline.
It was found that a constant flow of organic 
solvent, water-droplet free, could be obtained for the 
UV cell more readily when the proportion of organic 
phase to HPLC aqueous phase was about 2;1. For an HPLC 
column of 4.6 mm I.D. the most commonly used flowra'te 






















Organic Flow Rate (ml.min
Figure 5.1. Efficiency of the phase separator at 
the different flow rates (Organic: 
Aqueous, 2:1).
PSI - Phase separator I
PSIIa is without cleaning channel, while 
PSIIb is with the cleaning channels 
connected.
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post-column should be kept to a minimum to minimise 
analyte band broadening,and would often be about
0.25 ml min-1. This meant that an organic flowrate of 
about 2.5 ml min-1 would be required. Since this 
exceeded the capacity of the phase separator tested, a 
modified version, PSII was designed by Dr T.M.
Jefferies and made in the University. The three major 
differences in the design, Fig. 2.8, were:
a) The dimension of the main channel was increased to 
1 x 1 x 32 mm,
b) the addition of a second channel (1 x 1 x 24 mm) to 
remove water droplets from the organic phase,
c) the addition of a third channel (1 x 1 x 24 mm) to 
remove organic solvent droplets from the aqueous 
phase. This meant that the aqueous phase could also 
be cleaned and used as the phase monitored by the 
UV cell, if required.
Fig. 5.1 shows that when only the main channel was 
used as in PSIIa, the proportion of organic phase 
passing through the detector was consistently about 
60%, similar to the best performance of PSI. However it 
was able to produce this over the entire range tested, 
namely 1.5 to 4.25 ml min When the second channel 
was connected, PSIIb, it was found that all the organic 
solvent passed through the detector cell, over the same 






Figure 5.2. Organic and Aqueous segments flowing 
through a PTFE coil.
Table 5.1 The effect of coil diameter on segment 


















5.0 30 17 0.57
6.0 30 23 0.75
6.7 30 30 1.00
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expected that higher flowrates would be needed, in view 
of the cost of high quality organic solvents, the 
capacity of the phase separator was not tested any 
further.
Since the completion of these studies, a phase 
separator designed for HPLC has become commercially 
available from the Dept, of Analytical Chemistry, Free 
University, Amsterdam. Its design and performance have 
been described by de Ruiter £t al. (116), and works on 
the same wetting principle as the Kinkel and Tomlinson 
model (5) used in this thesis. It has a single channel, 
10 mm long, total volume 40 ul, and the authors 
recommend that it is used with an aqueous- organic 
ratio of (1:1 % v/v) at 1 ml min  ^ of each phase. Under 
these conditions, it will deliver about 35% of the 
organic phase to the detector cell.
5.2 EFFECT OF EXTRACTION COIL DIAMETER AND FLOW RATE
ON SEGMENT STABILITY
The extraction of derivatized analytes into an 
organic phase from an aqueous phase can be achieved 
simply and continuously by segmentation of the two 
phases, followed by their passage through a tubular 
coil. It has been found in this study that a PTFE 'Tee' 
piece with an internal diameter of about 0.8 mm makes a 
satisfactory segmentor and when connected to PTFE 
tubing of 0.8 mm I.D. produces segments 2-4 mm wide for
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aqueous-organic phases that are in a volume ratio 1:2.
In order to achieve efficient extraction, the 
tubing needs to be coiled to introduce centrifugal 
force effects upon the moving segments. This force is 
at right angles to the direction of liquid flow and so 
the combined effect is to make the segments thinner and 
wider (Figure 5.2). If this effect is too great then 
alternate segments coalesce into single larger segments 
so that the number of segments per centimetre leaving 
the coil is less than that entering the coil. This 
would be detrimental and produce unacceptable analyte 
band broadening. It is important therefore to determine 
the smallest coil diameter consistent with segment 
stability. This is defined as:
number of segments in 5 cm leaving the coil
number of segments in 5 cm entering the coil
and ideally should be 1.0.
It was found that segment stability was related to 
coil diameter at the flow rates used (0.70-1.30 
ml.min-1 aqueous + 1.30-2.60 ml.min”1 organic), and 
that good stability could be achieved with a coil 
diameter greater than 6 cm. Segment stability was 
studied with phase separator II at ten different 
flowrates over the range 2.0 to 6.3 ml.min”1, and 
excellent stability ( * 1.0) was obtained (Table 5.1).
It was noticed that segment size decreased as the fldw 
rate increased, from 1.3 ml at 2.0 ml.min”1 to 0.85 yl
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at 6.3 ml.min Since better liquid-liquid extraction 
can be expected with smaller segment volumes, this is 
an unexpected advantage of using high flowrates.
However even the 1.3 yl segments can be considered to 
be satisfactory, considering that most HPLC peaks elute 
in a volume of at least 1 ml.
5.3 INFLUENCE OF pH AND PENTAN-1-OL ON THE TRANSFER
OF NS TO THE ORGANIC PHASE
Naphthalene-2-sulphonate (NS) has been extensively 
studied as a UV-indicating ion-pair reagent by Crommen 
et al. (117, 118), and used in straight phase chroma­
tographic conditions. This was achieved by loading a 
silica column with an aqueous buffered solution of NS 
and then displacing the aqueous phase between the 
silica particles with a mobile phase of 
chloroform-pentan-l-ol. In this system, injected 
solutes such as alkylamines would form ion-pairs with 
NS in the aqueous stationary phase within the silica 
pores, and then transfer by liquid-liquid partition 
into the mobile organic phase. The alkylamines would be 
detected as their NS ion-pairs. NS was chosen because 
it has a very low distribution to the mobile phase, 
even at pH 2.5, so that it was considered to be 
suitable not only for amines, but also for amino acids 
and dipeptides that are in cationic form only at 
pH < 3. The molar absorptivity (e) of NS is about 1400
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at 254 nm (118) which was sufficiently high to obtain 
detection of the alkylamines down to about 10 ng. 
Earlier studies by Farrell and Jefferies (2) had found 
this straight phase system to be difficult to control 
because of excessive baseline noise and the 
unpredictable loss of significant volumes of the 
stationary phase, rendering the system unusable. 
However, the proven suitability of NS as an ion-pair 
reagent for amines between aqueous-chloroform phases 
meant that it could provide a starting point for the 
development of a post-column ion-pair extraction 
system, having the same sensitivity, but better 
stability than the straight phase system.
The transfer of a protonated amine, HA+ , from an 
aqueous solution containing an excess of an oppositely 
charged ion-pairing reagent such as naphthalene-2- 
sulphonate, NS , into an immiscible organic phase 
occurs as the ion-pair of the amine, HANS.
[ ] denotes molar concentrations.
The pH of the aqueous phase will influence the 
extraction of HANS due to
HANS
which is described by the extraction constant
KEX(HANS) [HANS]org / [ HA+] aq [NS- ]aq
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which shows that whilst an acidic pH is necessary for 
protonation and good aqueous solubility of the organic 
amine, at a sufficiently low pH the ionisation of NS 
will be suppressed and NS will partition into the 
organic phase. The optimum pH for minimum transfer of 
NS to the organic phase whilst providing maximum 
protonation of organic amines was therefore required to 
be determined experimentally.
Chloroform is suitable as the major component of 
the organic phase because it separates well from water 
due to its high density (1.47 gml”'*') and is therefore 
good for segmentation purposes and works well in a 
phase separator. Its solubilization ability is largely 
due to its proton donor property (119).
The addition of a proton acceptor solvent such as 
pentan-l-ol, which has very little solubility in water, 
considerably increases the solvating strength of the 
chloroform phase. This would increase the extraction 
efficiency of the organic phase for analyte-NS 
ion-pairs, but also for the NS reagent, which would 
raise the baseline absorbance. The influence of % v/v 
pentan-l-ol added to the chloroform was determined 
using the post-column system under constant 
chromatographic conditions. The absorbance of the 
organic phase due to the transfer of NS reagent was 
measured off-line using a UV-VIS spectrophotometer 


















Figure 5.3. Influence of pentan-l-ol concentration 
(%, v/v) on NS transfer for organic 
phase, (a - 254 nm; b - 274 nm)
Conditions
1. Organic phase - chloroform + pentan-l-ol 
(variable % composition).






















4 .  UV absorption spectrum of
a) 90% v/v chloroform + 10% v/v pentan-l-ol
b) 90% v/v chloroform + 10% v/v pentan-l-ol, 
equilibrated with chromatographic 
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Figure 5.5. Influence of pH change on NS transfer
to organic phase, (a = 254 nm; b = 274 nm) 
Conditions
Organic phase - chloroform + pentan-l-ol
(95% v/v + 5% v/v)
Aqueous phase - mobile phase + NS reagent
(variable pH).
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Absorbance was found to be linearly related to % v/v 
pentan-l-ol present, at both wavelengths used. The 
greater absorbance at 254 nm is mainly due to the 
greater absorbance of chloroform and pentan-l-ol at 
that wavelength compared to 274 nm, Fig. 5.4. These 
results indicated that for minimum background noise, it 
was preferable to restrict the % v/v pentan-l-ol to 
5-10% and monitor at 274 nm.
The optimum pH range for the minimum transfer of NS 
reagent to the organic phase was then determined by 
maintaining the % pentan-l-ol in the organic phase to 
5%, by keeping the chromatographic conditions constant 
but varying the pH of the NS reagent added post-column. 
Fig. 5.5 shows that at 274 nm the minimum pH is about 
3.0, with little change in absorbance noted up to pH 
5.5. The absorbance at 254 nm was at least three times 
greater, with a minimum at pH 3.5.
5.4 QUANTITATIVE STUDIES USING HPLC WITH POST-COLUMN
EXTRACTION DETECTION
As a result of the preliminary studies to optimise 
the performance of the components of the post-column 
system, the following conditions were selected for the 
preparation of calibration curves for some of the Group 
A compounds,
a ) Chromatography
Column: Hypersil-SAS, and Nucleosil-SA were both
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studied.
Mobile phase: 0.02 M phosphate buffer (pH 5.4) - 
methanol - acetonitrile (90:5:5; % v/v/v)
b) Ion-pair reagent
0.01 M Na naphthalene-2-sulphonate in 2.0 pH.
c ) Reactor
20 x 2 mm I.D. column packed with 150-200 ym 
ballotini beads.
d ) Organic phase
Chloroform-pentan-l-ol (90:10 % v/v) equilibrated 
with aqueous phase (mobile phase + NS reagent).
e ) Segmentor
Tee piece, PTFE, 0.8 mm I.D.
f ) Extraction
PTFE tubing, 3 metre x 0.8 mm I.D. 6.7 cm coil 
diameter.
g) Detection
UV at 274 nm, 0.02 AUFS.
5.4.1 Nucleosil SA
Figure 5.6 shows a typical chromatogram for the 
resolution of seven Group A compounds obtained using 
the post-column system. It was found that p-hydroxy- 
norephedrine, p-hydroxyamphetamine, and p-hydroxy-N- 
methylamphetamine were poorly detected because of their 
strongly polar functional groups and acidic nature of 
the reagent-eluent aqueous phase (pH 3.0-3.5) reduced
Figure 5,6.
Post-column conditions for the calibration of some 
Group A compounds.
Aqueous phase
a) stationary phase: Nucleosil SA 5 m 50 mm x 4.6 mm 
mobile phase: 82.5% (v/v 0.2 M KP^PO^ (pH 5.0)
10% v/v methanol + 7.5% v/v 
acetonitrile.
Temperature: 57°C*
Flow rate: 1 ml/min
Injection volume: 10 yl
b)0.01M Sodium naphthalene-2-sulphonate 
Flow rate: 0.30.ml/min
Organic phase
90% v/v chloroform + 10% v/v pentanol 
Flow rate: 2.6 ml/min
274 nmmax
* Aqueous phase was always cooled down from 57°C with 
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Figure 5.6. Typical post-column separation of 
some Group A compounds, variable 
concentrations. Conditions as 
on opposite page.
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Figure 5.7 Highest (a) and lowest (b) concentrations for 
the Post-column calibration of dexamphetamine 
(5), methylamphetamine (7) and mephentermine 













Concentration ( y g.ml” )^
Figure 5.8 Five-point calibration of Dexamphetamine (5).









Figure 5.9 Calibration of methylamphetamine (7), mephentermine (9).
Conditions as in Figure 5.6.
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the extraction of the ion-pair into the chloroform 
layer, and so these compounds were not studied 
quantitatively.
Five calibration solutions were made for a mixture 
containing dexamphetamine (2.5-7.5 yg ml methyl­
amphetamine (10-30 yg ml-1) and mephentermine (10-30 
yg ml-1), and Fig. 5.7 shows the chromatograms for the 
highest and lowest concentrations in this mixture. 
Linear calibrations were obtained for each compound 
(Fig. 5.8, 5.9) with correlation coefficients >0.999 
and relative standard deviations (n = 10) < ± 1.52%, 
even though no internal standard was used (Table 5.2).
Table 5.2. Statistical analysis of the results for the 
calibration of dexamphetamine (5), methyl 
amphetamine (7) and mephentermine (8). 
Conditions as in Figure 5.1.

























Figure 5.10 is a typical chromatogram of the 
separation of seven Group A compounds. The three 
p-hydroxy-metabolites were not included here because of 
the reasons given under nucleosil. Figures 5.11(a) and 
5.11(b) are the chromatograms of the highest and lowest 
concentrations for calibration while Figures 5.12-5.14 
are 5-point calibration plots for a mixture containing 
2-phenylethylamine (4) (15-60 ygml ^), dexamphetamine 
(5) (15-60 ngml 1), phenmetrazine (6) (25-100 ygml-1), 
methylamphetamine (7) (33-120 ygml ^), phenedimetrazine 
(9) (25-100 yg ml ^), mephentermine (8) (33-120 ygml-'1') 
and chlorphentermine (10) (25-100 ygml”1 ). Linear 
calibrations were also obtained for each compound with 
correlation coefficients > 0.99, except for 
phenmetrazine which is 0.943, intercepts were small and 
relative standard deviations (n = 10)<±1.7% without 
the use of an internal standard (Table 5.3).
Figure 5.10.
Post-column conditions for the calibration of some 
Group A compounds.
Aqueous phase
a) stationary phase: Hypersil SAS 100 x 2.1 mm








Injection volume: 10 yl
b) 0.01M Sodium naphthalene-2-sulphonate
Flow rate: 0.15 ml/min
Organic phase

























Figure 5.10 T ypical post-c o l u m n  separation of some 
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Figure 5.11a Highest concentration for the post-column 
calibration of some Group A compounds. 
Compounds and conditions as in 
Figure 5.10.
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Figure 5.11b Lowest concentration for the post-column 
calibration of some Group A compounds. 







Figure 5.12. Calibrations of 2-phenylethylamine (3) and dexamphetamine (5)
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Figure 5.13 Calibrations of methylamphetamine (7) and phendimetramine
(8). Conditions as in Figure 5.10.
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Figure 5.14 Calibrations of phenmetrazine (6), phendimetrazine (9)
chlorphenmetrazine (10). Conditions as in Figure 5.10.
Table 5.3. Statistical analysis of the calibration of 2-phenylethylamine (4), 
dexamphetamine (5 ), phenmetrazine (6), methylamphetamine (7), 
phendimetrazine (9), mephentermine (8) and chlorphentermine (10). 
Conditions as in Figure 5.11.
Compounds 3 • 5 6 7 8 9 10
Correlation
Coefficient 0.9990 0.9965 0.9425 0.9987 0.9988 0.9985 0.9927
Slope 1.264 1.796 1.210 1. .1.7 1.08 0.9295 0.6447
Intercept 0.36 2.14 0.486 0.70 0.60 -2.754 -0.758
Std. dev. of 
slope 0.0236 0.0611 0.1726 0.0241 0.0213 0.0207 0.03193
Std. dev. of 
Intercept 0.9045 2.345 11.039 1.8499 1.6354 1.3249 2.0421






Numerous workers in the last few years have 
strived to improve both methodology and sensitivity in 
the analysis of compounds of forensic interest. In 1973 
Cashman et a^. (121) used long stainless steel columns 
(1500 x 2 mm ID) packed with pellicular silica material 
(Corasil II) to separate phenethylamines and compared 
the results with that of an ion-exchange material 
(DA-X4) packed in glass columns (250 x 6 mm i.d.). They 
found that the ion-exchange material gave better 
separations at a pH of 9.0 and at 64°C. However peaks 
were broad and sensitivities not good due to low column 
efficiencies.
With the introduction of fully porous micro­
particulate silica (10 ym), column efficiencies 
improved dramatically, which was further improved when 
5 um material became readily available. In 1975 Jane 
(122) described the use of 6 \i m Partisil silica as 250 
x 4.6 mm I.D. columns to separate a wide range of drugs 
of abuse using methanol-2N ammonia solution-lN ammonium 
nitrate solution (27: 2: 1, % v/v) and UV detection at 
254 nm. It was particularly suitable for the 
identification and quantitation of mixtures of basic 
drugs because peak shapes were good and most analyses 
required 15 mins or less. Sensitivity limits were 
dependent upon the molar absorptivity of each compound
at 254 nm. Achari et^  a^. in 1977 (123) also used silica 
(Partisil 10 ym) with methanol-dichloromethane (3:1, 
v/v) containing 1% v/v ammonium hydroxide (29% NH^) for 
pharmaceutical dosage forms of 29 basic drugs, and 
found the columns did not deteriorate due to the 
alkali, probably due to the low water content. The 
importance of the brand of silica chosen for this type 
of system was demonstrated in 1984 by Law, Gill and 
Moffat (124) who compared the retentions of a 
7-component test mixture on Hypersil, Spherisorb S5W, 
Nucleosil 50-5 and Zorbax BP-Sil. Although no 
alterations in retention order occurred, total analysis 
times varied from 4 to 6 minutes using a mobile phase 
of methanol-aqueous ammonium nitrate buffer, pH 10.1 
(9:1 % v/v). Spherisorb S5W was selected to examine the 
retention behaviour of 84 basic drugs of forensic 
interest. Although peak shapes were good, k 1 values 
were in a small range, for example for 36 amphetamine- 
related compounds k' = 0.14 to 2.48. Whilst this 
provided short analysis times it also meant that the 
system was not very selective, having limited 
discriminatory power. The retention mechanism of this 
chromatographic system was thoroughly investigated by 
Law in 1987 (125) who concluded that it was mainly a 
cation-exchange mechanism influenced by solute pKa (in 
the range 8-11) and the stereochemistry and degree of 
substitution at or near the basic centre. Because
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Spherisorb S5W had been chosen as the standard silica 
material for use throughout the Forensic Science 
Service Laboratories in the U.K., this material was 
used by Jane et_ al. in 1985 (126) for a very 
comprehensive study using 462 basic drugs. Their 
retentions were determined using methanolic ammonium 
perchlorate (10 mM) plus 1 ml/1 methanolic sodium 
hydroxide (0.1 M ) pH 6.7, and their relative detection 
responses by UV at 254 nm and electrochemical at +1.2 V 
compared. The relative response ratio was found to 
cover a wide range that could be used to considerably 
improve the possible identification of analytes. This 
was necessary because only 15 analytes had k' > 6.0. 
Electrochemical detection was much more sensitive than 
UV at 254 nm, but limits of detection were not 
investigated. For aliphatic amines, the ease of 
oxidation is tertiary > secondary > primary so that for 
the compounds studied in this thesis, EC detection 
would have the disadvantage of having a wide range of 
sensitivity limits. The authors showed that this 
chromatographic system could be used with post-column 
derivatisation using fluorescence with 2-mercapto- 
ethanol-O-phthalaldehyde for primary amines such as 
amphetamine, with a sensitivity limit probably about 
20 ng on-columm. UV at 215 nm and 0.03 AUFS was 
sensitive down to about 25 ng of amphetamine. The 
authors suggested that 205 nm could be used but did not
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use this wavelength. Since methanol (Fisons, HPLC 
grade) has an absorbance of 0.4 at 210 nm, it is 
unlikely that the solvent systems used by the silica 
column methods described above would be able to improve 
upon that achieved at 215 nm.
Reversed-phase column materials have been less 
successful for basic compounds due to excessive 
retention caused by residual silanol groups on the 
bonded silica surface. Twitchett and Moffat (127) found 
n -Bondapak-C-^g to be suitable for acidic and neutral 
compounds but not basic compounds of forensic interest. 
Although Baker et a^ L. (128) obtained better column 
efficiencies using the same packing material, 
selectivity was very limited, and they proposed using 
the ratio of analyte absorbances at 254 nm and 280 nm 
in order to assist peak identification.
Cation exchange chromatography was examined by 
Twitchett e_t al. (129) for 30 compounds of widely 
differing structures and found to be useful for basic 
substances although column longevity was questionable.
In all the above cases, high carbon loading 
materials coupled with high percentage of organic 
eluents have been used, and selectivities are also low. 
In this thesis, two approaches to detecting these 
compounds of abuse have been developed:
i) HPLC using columns with low carbon loadings,
monitored at 205 nm. In this approach short (50 mm and
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100 mm) and narrow bore (2 mm) analytical columns have 
been found to provide selective and sensitive detection 
for all the compounds studied. Analytical times are 
easily adjusted by alteration of the percentage of 
organic modifiers.
ii) Post-Colum Derivatization. The low percentage of 
organic modifiers (5% methanol + 5% acetonitrile) in 
the mobile phase developed for Group A compounds meant 
that this chromatographic system could be used with a 
post-column extraction detection method. This approach 
using sodium naphthalene-2-sulphonate, and described in 
Section 5, was found to be more complex to assemble and 
operate, but linear calibrations were obtained even though 
.detection was not enhanced as anticipated.
It is appropriate to compare the results 
obtained using the two approaches.
6.1 Assessment of Chromatographic Peaks
It is highly desirable that analyte peaks should 
be tall, narrow and symmetrical in order to maximise 
sensitivity and range of linearity in calibration 
curves. This can be more readily achieved when 
chromatographic conditions are chosen to produce 
predominantly low k' values. However the objective of 
this study was to develop systems with good 
selectivity, which meant that the k' range must be 
large enough to accommodate all the analytes on the
chromatogram. This was achieved with Hypersil-CN, 
Hypersil-SAS and Nucleosil SA, as described in Section 
3. Hypersil-SAS and Nucleosil SA were also both 
employed using identical chromatographic conditions but 
with post-column ion-pair extraction detection as 
described in Section 5, and so the chromatograms of 
these two procedures may be compared directly. Table
6.1 summarises the relevant data.
6.1.1 Peak Widths (W)
These were measured at 10% peak height and 
converted into seconds. For the Nucleosil SA system 
used at 205 nm the peak widths were between 18 and 48 
secs for k 1 values between 0.43 and 9.0. This is 
satisfactory considering the good resolutions obtained. 
When this system was used with the post-column detector 
conditions as in Fig. 5.1 and 5.2, peak widths were 
increased by 6 to 8 secs, representing a 15% increase. 
Considering the complexity of this system, this is also 
very satisfactory.
The Hypersil SAS system gave excellent 
selectivity but required a wider range of k' values, 
leading to increased peak widths, 18 to 84 secs for k' 
values between 2.43 and 14.0. These widths were further 
increased by 12 to 18 secs when the post-column system 
was added under the conditions in Fig. 5.10, 
representing a 20-33% increase. This is less
H Y P E P S  I I  S A S
k*
Chromatography at 205 nm
Condition as in Figures 3.23 and 3.32
t^ W (sec) As statistical 
at 10% moment 
(min) of the 
base
Post-Column at 274 nm 
Conditions as in Figures 5.
t W (sec) As 
at 10%







sec % of W
4 2-phenylethylamine 2.43 5.40 35.0 1.0 0.48 7.50 48.0 1.0 0.86 12.0 33.3
5 Dexamphetamine 4.0 6.20 42.0 1.1 0.69 8.10 54.0 1.15 1.16 12.0 28.6
6 Phemetrazine 4.5 7.70 48.0 1.13 0.91 9.60 60.0 1.3 1.52 12.0 25
7 Methylamphetamine 5.43 9.50 60.0 1.50 1.64 11.60 72.0 1.9 2.71 12.0 20
8 Phendimetrazine 8.30 14.10 66.0 1.15 1 .73 16.0 84.0 1 .4 3.09 18.0 27
9 Mephentermine 7.14 12.0 60.0 1.40 1.58 14.0 72.0 1.8 2.64 12.0 20
10 Chlorphentermine 14.0 20.0 84.0 1.0 2.63 22.0 102.0 1.3 4.38 18.0 21
N U C L E O S I L  S A
1 p-OH-norephedrine 0.43 1.2 18.0 1.0 0.12 2.70
2 p-OH-amphetami ne 1.6 1.8 18.0 1.0 0.12 3.10
3 p-OH-methylamphetamine 2.3 2.3 24.0 1.0 0.21 3.58
4 2-phenylethylamine 2.6 2.5 24.0 1.1 0.22 3.80
5 Dexamphetamine 4.0 3.5 30.0 1.1 0.35 4.80 36.0 1.13 0.51 6.0 20
G Phenmntrozlne D. 14 4.3 42.0 1 .12 o. no 5. GO
7 Methylamphetarni ne 6.43 5.2 42.0 1 .8 0.00 6.4 48.0 1 .25 0.95 6.0 14.3
8 Phendimetrazine 8.0 6.3 48.0 1 .8 1.17 7.58
9 Mephentermine 9.0 7.0 48.0 1.25 0.95 8.0 54.0 1.29 1.22 6.0 12.5





satisfactory and is probably caused by the lower 
aqueous and organic flowrates employed here,compared to 
the Nucleosil SA system.
6.1.2 Peak Asymmetry (As)
Chromatographic systems for basic compounds 
frequently display asymmetrical peaks due to excessive 
interaction between acidic silanol groups and 
protonated amines. This can result in a substantial 
loss of sensitivity and resolution. Table 6.1 and 
Figs. >3.10 show that the three low carbon column 
materials used in this thesis gave peaks that for most 
analytes were satisfactory (As = 0.9 - 1.2). A few more 
basic analytes such as methylamphetamine, 
phendimtrazine, gave higher values (As = 1.5-1.8) but 
even these are not excessive. A possible explanation 
for the better performance of the cyanopropyl-, short 
alkyl- and ion-exchange materials compared to ODS 
materials is that the surface coverage of the low 
carbon materials is much higher so that fewer silanols 
remain to cause analyte tailing. A direct comparison of 
the peaks generated by the post-column system with 
those generated at 205 nm, Table 6.1, show only a 
slight increase in asymmetry (As = 1.0-1.9). This is 
surprising considering the two 'tee' pieces, 3 metres 
of tubing and phase separator between the analytical 
column and detector cell, and clearly illustrates the
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effectiveness of segmented flow in maintaining analyte 
band integrity.
6.2 Analysis Time
The analysis times required for the three column 
systems developed here are guidelines only and are 
capable of considerable modification according to the 
range of analytes chosen and mobile phase composition 
selected. Column efficiency is also an important factor 
which influences the mobile phase flowrate. However, 
the three systems all produced chromatograms with the 
analytes regularly eluted, with little time wasted. It 
is felt that the cyanopropyl column in particular would 
be very suitable as a more selective alternative to the 
silica-methanolic ammonium nitrate system currently 
used to identify basic drugs.
The post-column system increased the analytical 
time byilminute for the Nucleosil SA column (total 
flowrate 4 ml min”"*") and by 2 minutes for the Hypersil 
SAS system (total flowrate 2 ml min"*1), Table 6.1. 
Considering the complexity of the system, this is a 
very small increase.
6.3 Sensitivity and Ease of use
A comparison of the sensitivity of detection at 
205 nm compared with post-column detection at 274 nm, 
in Table 6.2 for Group A compounds, shows that the
Table 6.2.
Compound log P Minimum level of Detection 
205 nm Post-column 274 nm 
(ng) (ng)
p-OH-norephedrine 0.18 2 250
p-OH-amphetamine 0.20 2 250
p-OH-N-methylamphetamine 0.22 2 250
2-phenylethylamine 0.22 2 20
dexamphetamine 0.63 2.5 25
methylamphetamine 0.82 3.0 100
chlorphentermine 1.10 4.0 -
phenmetrazine 1.02 2.5 50
phendimetrazine 2.06 3.5 50
223.
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former is much more sensitive. For analytes that are 
very polar, such as the hydroxylated metabolites, 
extraction into the chloroform-pentan-l-ol phase, even 
as NS ion-pairs, was inadequate. The addition of a 
p-hydroxyl group to dexamphetamine raised its detection 
limit from 25 to 250 ng on-column. Whilst the 
extraction could probably be improved by making the 
organic phase more polar, it is unlikely that dramatic 
improvements would be obtained.
For the other analytes in Table 6.2 that are 
less polar (log P range 0.18 to 2.06) the levels of 
detection using the post-column system areio to 20 
times higher than for the 205 nm system. Fig. 6.1 
illustrates the enormous increase in sensitivity at 205 
nm compared with 254 nm for a mixture of 
p-hydroxynorephedrine, p-hydroxyamphetamine, 
dexamphetamine, methylamphetamine and mephentermine. 
Fig. 6.2 illustrates the differences betwen 205 nm 
detection and post-column detection at 274 nm for the 
same mixture of compounds. It clearly demonstrates the 
lack of sensitivity of the post-column system towards 
the two hydroxylated metabolites.
In view of the relative simplicity of the 205 nm 
system and its greater sensitivity, this method is 
preferred. The cyanopropyl- column is recommended 
because of th,e shorter retention times and because no 
problems were encountered with column stability. No
Figure 6.1 Chromatograms of separation of some 
Group A compounds of variable 
concentrations. UV detection at:
a) 205 nm
b) 254 nm
Other conditions as in Section 3.3.
1 2 5 7 9






Figure 6.2 Chromatograms of separation of some
Group A compounds (variable concentrations)*
a) Chromatography UV detection at 205 nm 
conditions as in Fig. 6.1.
b) Post-column UV detection at 274 nm 
conditions as in Fig. 5.6.
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differences were noted between Hypersil-CPS and 
Spherisorb-Cyano materials. This method relies upon 
using good quality organic solvents and buffer salts to 
ensure a minimum UV background absorbance, and the use 
of a UV lamp with a good output at 205 nm. This output 
decreases as the lamp ages, and needs to be monitored 
regularly.
The post-column extraction detection system gave 
good linear calibrations but was more complex to use 
and adjust. In view of this and the sensitivity levels 
achieved, this method should be regarded as potentially 
useful but still in an early stage of development.
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Suggestions for Further Work
1. The cyanopropyl- column could be used with the 
mobile phase developed for Group B compounds as 
a more sensitive and selective replacement for 
the silica column - methanolic ammonium nitrate 
system. The wider range of k' values obtained, 
plus dual UV detection at 205 nm and, say 254 nm 
would provide a better basis for peak 
identification.
2. Further work should be carried out on the post­
column system to improve sensitivity levels. 
Different ion-pair reagents, including
9,10-dimethyoxyanthracene sulphonate for 
fluorescence detection, should enable much lower 
limits of detection to be obtained. The phase 
separator requires modification to permit its 
use without solvent leakage occurring.
3. It would be useful to make a systematic study of 
the effect of methanol, acetonitrile and 
propan-2-ol on analyte pKa values, so that a 
figure similar to that obtained for the effect 
of temperature may be determined. The 
possibility of an additive effect between 
organic modifier and temperature should also be 
considered. It should be possible for a study of
229.
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Figure 2.8.
Configuration of phase separator for monitoring 
the organic phase.
Flowpath of organic phase:
1. Aqueous/organic segmented flow inlet
2. Separated organic phase plus some aqueous droplets
3. Re-entry into second separating channel
4. Exir of clean, organic phase to derector
Flowpath of aqueous phase:
1. Aqueous/organic segmented flow inlet
5. Exit of aqueous phase
6 Exit of any water droplets + some organic phase
The separator may also be configured tc monitor the 
aqueous phase by connecting exit 5 to re-entry 7 and 
connection of exit 8 to the detector.
Exits 9 and 10 are for "waste" organic phase
Figure 3.1 Influence of mobile phase pH on the 
retention of some Group A compounds. 
Conditions: 5 ym Spherisorb-CN column 
(50 x 4.6 mm i.d.) with 0.05 M phosphate 
buffer-methanol-acetonitrile (90:5:5, 
v/v/v) at 30°C. Injection volume 10 yl, 
flow rate 1 ml.min-1, monitored at 205 nm 
with 0.04 a.u.f.s.














Figure 3.25 Chromatograms of the highest (a) 
and lowest (b) concentrations for 
the calibration of p-hydroxynorephedrine 
(1), p-hydroxyamphetamine (2), p-hydroxy- 
methylamphetamine (3), dexamphetamine (5), 
methylamphetamine (7). Injection volume 
(10 1) contained 10-80 yg.ml
Conditions as in Fig. 3.23.
Figure 3.28 Chromatograms of the highest (a)
and lowest (b) concentration for the 
calibration of p-hydroxynorephedrine 
(1), p-hydroxyamphetamine (2), 
p-hydroxymethylamphetamine (3), 
dexamphetamine 95) and methyl- 
amphetamine (7) (2-20 yg.ml ^ ) . 
Conditions as in Figure 3.23 
(except for flow rate 0.5 ml/min).
Conditions for Figure 3.10(a)
5 - um CPS - Hypersil column (50 x 4.6 rrm.i.d) with 0.025 M 
Phosphate buffer (pH 7.2) - methanol-acetonitrile (90:5:5/ 
V/V/V) at 30°C, 1 ml.min.  ^flowrate monitored at 205 nm,
0.04 a.u.f.s.
Injection volume (10 pi) contained 6-12 ng of each solute.
Conditions for Figure 3.10(b)
Same as fig 3.10(a) but with a mobile phase of 0.02 M 
Phosphate buffer (pH 4.0) - propan-2-ol-acetonitrile 
(65:17.5:17.5, V / V / V ).
Injection volume (10 pi) contained about 12 ng of each 
solute.
tFigure 3.30(a) Chromatogram of the highest concentration
(4.0 pg.ml for the calibration 
of Group B compounds. Conditions and 
solute code as in Figure 3.27.
Figure 3.14 Chromatogram of the separation of
Group B compounds. Conditions: 5 yin
Spheri-Cyano cartridge column (100 x 2.1 mm
i.d.) with a mobile phase of 0.025 M phosphate
buffer - propan-2-ol - acetonitrile
(76: 12: 12- v/v/v) at 40°C. Injection
volume (10 yl). Flow rate was
0.5 ml.min monitored at 205 nm with
0.04 a.u.f.s. Compounds as in
Figure 3.10b.
Conditions for Figure 3.7
In all investigations 65% v/v 0.2 M 
buffer (pH 3.1)was used with:
A. 35% v/v Tetrahydrofuran (THF)
B. 35% v/v Propan-2-ol (Pr-2-OE)
C. 35% v/v Acetonitrile (ACN)
D. 17.5% : 17.5% v/v Pr-2-OH-AC.'I
E. 17.5%: 17.5% v/v THF-ACN
F. 17.5% : 17.5% v/v THF-Pr-2-OH
phosphate
Post-column conditions for the calibration of some 
Group A compounds.
Aqueous phase
a) stationary phase: Nucleosil SA 5 m 50 mm x 4.
mobile phase: 82.5% (v/v 0.2 M KI^PO^ (pH
10% V/v methanol + 7.5% v/v 
acetonitrile.
Temperature: 57°C*
Flow rate: 1 ml/min
Injection volume: 10 yl
b)0.01M Sodium naphthalene-2-sulphonate 
Flow rate: 0.30 ml/min
Organic phase
90% v/v chloroform + 10% v/v pentanol
Flow rate*. 2.6 ml/min
„ v : 274 nmmax
* Aqueous phase was always cooled down from 57°C 













Post-column conditions for the calibration of some 
Group A compounds.
Aqueous phase
a) stationary phase: Hypersil SAS 100 x 2.1 mm








Injection volume: 10 yl
b) 0.01M Sodium naphthalene-2-sulphonate
Flow rate: 0.15 ml/min
Organic phase




















Figure 6.1 Chromatograms of separation of some 
Group A compounds of variable 
concentrations. UV detection at:
a) 205 nm
b) 254 nm
Other conditions as in Section 3.3.
CHROMATOGRAPHIC STUDIES ON THE DETECTION 
OF SOME BASIC DRUGS OF ABUSE
Thesis
Submitted by SHEWU OLADAPO BADIRU, M.Sc. (Pharm) 
for the degree of Doctor of Philosophy 
of the University of Bath 
1989
Figure 6.2 Chromatograms of separation of some
Group A compounds (variable concentrations).
a) Chromatography UV detection at 205 nm 
conditions as in Fig. 6.1.
b) Post-column UV detection at 274 nm 
conditions as in Fig. 5.6.
